astc-10q_20190930.htm

0001564590-19-043442.txt : 20191114 0001564590-19-043442.hdr.sgml : 20191114 20191114130156 ACCESSION NUMBER: 0001564590-19-043442 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 57 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191114 DATE AS OF CHANGE: 20191114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ASTROTECH Corp CENTRAL INDEX KEY: 0001001907 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 911273737 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34426 FILM NUMBER: 191218446 BUSINESS ADDRESS: STREET 1: 201 W. 5TH STREET STREET 2: SUITE 1275 CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 5124859530 MAIL ADDRESS: STREET 1: 201 W. 5TH STREET STREET 2: SUITE 1275 CITY: AUSTIN STATE: TX ZIP: 78701 FORMER COMPANY: FORMER CONFORMED NAME: ASTROTECH Corp \WA\ DATE OF NAME CHANGE: 20090310 FORMER COMPANY: FORMER CONFORMED NAME: SPACEHAB INC \WA\ DATE OF NAME CHANGE: 19951006 10-Q 1 astc-10q_20190930.htm 10-Q astc-10q_20190930.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☑	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2019

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

Commission file number 001-34426

Astrotech Corporation

(Exact Name of Registrant as Specified in its Charter)

Delaware		91-1273737
State or Other Jurisdiction of Incorporation or Organization		I.R.S. Employer Identification No.

201 West 5th Street, Suite 1275, Austin, Texas		78701
Address of Principal Executive Offices		Zip Code

(512) 485-9530

Registrant’s Telephone Number, Including Area Code

Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value per share

ASTC

NASDAQ Stock Market, LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer		☑		Smaller reporting company		☑
Emerging growth company		☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☑

As of November 8, 2019, the number of shares of the registrant’s common stock outstanding was: 5,915,129.

ASTROTECH CORPORATION AND SUBSIDIARIES

QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

		Page
PART I:	FINANCIAL INFORMATION	4

ITEM 1.	CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)	4
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	16
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	21
ITEM 4.	CONTROLS AND PROCEDURES	21

PART II:	OTHER INFORMATION	22

ITEM 1.	LEGAL PROCEEDINGS	22
ITEM 1A.	RISK FACTORS	22
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	22
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES	22
ITEM 4.	MINE SAFETY DISCLOSURES	22
ITEM 5.	OTHER INFORMATION	22
ITEM 6.	EXHIBITS	23

PART I: FINANCIAL INFORMATION

ITEM 1. Condensed Consolidated Financial Statements

ASTROTECH CORPORATION AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(In thousands, except share and per share data)

	September 30, 2019			June 30, 2019
	(Unaudited)			(Note)
Assets
Current assets
Cash and cash equivalents	$	1,579		$	1,588
Accounts receivable		3			3
Inventory:
Raw materials		121			150
Work-in-process		209			181
Income tax receivable		643			429
Prepaid expenses and other current assets		338			371
Total current assets		2,893			2,722
Property and equipment, net		409			469
Operating leases, right-of-use assets		1,527			—
Long-term tax receivable		214			429
Other assets		72			72
Total assets	$	5,115		$	3,692
Liabilities and stockholders’ equity
Current liabilities
Accounts payable		99			160
Payroll related accruals		388			319
Accrued expenses and other liabilities		290			357
Income tax payable		2			2
Term note payable - related party		1,500			—
Operating lease liabilities - current		237			—
Total current liabilities		2,516			838
Operating lease liabilities, non - current		1,304			—
Other liabilities		—			146
Total liabilities		3,820			984
Commitments and contingencies (Note 12)
Stockholders’ equity
Convertible preferred stock, $0.001 par value, 2,500,000 shares authorized; 280,898 shares of Series C and 280,898 shares of Series D issued and outstanding at September 30, 2019 and June 30, 2019, respectively		—			—
Common stock, $0.001 par value, 15,000,000 shares authorized; 6,188,198 and 6,184,698 shares issued at September 30, 2019 and June 30, 2019, respectively; 5,926,137 and 5,775,171 shares outstanding at September 30, 2019 and June 30, 2019, respectively		190,597			190,571
Treasury stock, 399,916 shares at cost at September 30, 2019 and June 30, 2019, respectively		(4,129	)		(4,129	)
Additional paid-in capital		8,363			7,964
Accumulated deficit		(193,536	)		(191,698	)
Total stockholders’ equity		1,295			2,708
Total liabilities and stockholders’ equity	$	5,115		$	3,692

Note: The balance sheet at June 30, 2019, has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by the United States generally accepted accounting principles for complete financial statements

See accompanying notes to unaudited condensed consolidated financial statements.

ASTROTECH CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Operations and Comprehensive Loss

(In thousands, except per share data)

(Unaudited)

	Three Months Ended September 30,
	2019			2018
Revenue	$	1		$	33
Cost of revenue		—			11
Gross profit		1			22
Operating expenses:
Selling, general and administrative		1,202			1,144
Research and development		855			1,103
Total operating expenses		2,057			2,247
Loss from operations		(2,056	)		(2,225	)
Interest and other expense, net		(12	)		(13	)
Loss from operations before income taxes		(2,068	)		(2,238	)
Income tax benefit		—			—
Net loss	$	(2,068	)	$	(2,238	)
Weighted average common shares outstanding:
Basic and diluted		5,591			4,073
Basic and diluted net loss per common share:
Net loss	$	(0.37	)	$	(0.55	)
Other comprehensive loss, net of tax:
Net loss	$	(2,068	)	$	(2,238	)
Available-for-sale securities:
Reclassification adjustment for realized loss		—			31
Total comprehensive loss	$	(2,068	)	$	(2,207	)

See accompanying notes to unaudited condensed consolidated financial statements.

ASTROTECH CORPORATION

Condensed Consolidated Statement of Changes in Stockholders’ Equity

(In thousands)

(Unaudited)

	Preferred Stock
	Class C				Class D				Common Stock
	Number of Shares Outstanding		Amount		Number of Shares Outstanding		Amount		Number of Shares Outstanding		Amount		Treasury Stock Amount			Additional Paid-In Capital		Accumulated Deficit			Accumulated Other Comprehensive Loss		Total Stockholders’ Equity
Balance at June 30, 2019		281	$	—		281	$	—		5,775	$	190,571	$	(4,129	)	$	7,964	$	(191,698	)	$	—	$	2,708
Adjustment to opening retained earnings related to adoption of ASC Topic 842		—		—		—		—		—		—		—			—		230			—		230
Issuance of shares, net of offering issuance costs of $7		—		—		—		—		146		—		—			321		—			—		321
Stock-based compensation		—		—		—		—		—		—		—			78		—			—		78
Restricted stock issuance		—		—		—		—		5		26		—			—		—			—		26
Net loss		—		—		—		—		—		—		—			—		(2,068	)		—		(2,068	)
Balance at September 30, 2019		281	$	—		281	$	—		5,926	$	190,597	$	(4,129	)	$	8,363	$	(193,536	)	$	—	$	1,295

	Preferred Stock
	Class C				Class D				Common Stock
	Number of Shares Outstanding		Amount		Number of Shares Outstanding		Amount		Number of Shares Outstanding			Amount			Treasury Stock Amount			Additional Paid-In Capital			Accumulated Deficit			Accumulated Other Comprehensive Loss			Total Stockholders’ Equity
Balance at June 30, 2018		—	$	—		—	$	—		4,097		$	190,570		$	(4,128	)	$	1,745		$	(184,164	)	$	(31	)	$	3,992
Net change in available-for-sale debt and marketable equity securities		—		—		—		—		—			—			—			—			—			31			31
Stock-based compensation		—		—		—		—		—			—			—			44			—			—			44
Cancellation of restricted stock		—		—		—		—		(5	)		(14	)		—			—			—			—			(14	)
Forfeiture of stock options		—		—		—		—		—			—			—			(3	)		—			—			(3	)
Exercise of stock options		—		—		—		—		3			—			—			7			—			—			7
Share repurchases		—		—		—		—		—			—			(1	)		—			—			—			(1	)
Restricted stock issuance		—		—		—		—		—			9			—			—			—			—			9
Net loss		—		—		—		—		—			—			—			—			(2,238	)		—			(2,238	)
Balance at September 30, 2018		—	$	—		—	$	—		4,095		$	190,565		$	(4,129	)	$	1,793		$	(186,402	)	$	—		$	1,827

See accompanying notes to unaudited condensed consolidated financial statements.

ASTROTECH CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

	Three Months Ended September 30,
	2019			2018
Cash flows from operating activities:
Net loss	$	(2,068	)	$	(2,238	)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation		104			36
Depreciation and amortization		141			75
Net loss on sale of available-for-sale investments		—			31
Changes in assets and liabilities:
Accounts receivable		—			(17	)
Inventory		1			—
Accounts payable		(61	)		(7	)
Other assets and liabilities		53			(127	)
Net cash used in operating activities		(1,830	)		(2,247	)
Cash flows from investing activities:
Proceeds from sale of available-for-sale investments		—			3,345
Proceeds from maturities of securities		—			250
Net cash provided by investing activities		—			3,595
Cash flows from financing activities:
Payments for purchase of treasury stock		—			(1	)
Proceeds from term note payable - related party		1,500			—
Proceeds from exercise of stock options		—			7
Proceeds from issuance of stock, net of offering issuance costs		321			—
Net cash provided by financing activities		1,821			6

Net change in cash and cash equivalents		(9	)		1,354
Cash and cash equivalents at beginning of period		1,588			552
Cash and cash equivalents at end of period	$	1,579		$	1,906

Supplemental disclosures of cash flow information:
Cash paid for interest	$	—		$	—
Income taxes paid	$	—		$	—
Impact to retained earnings from adoption of ASC Topic 842	$	230		$	—
Operating right-of-use assets and associated liabilities	$	1,608		$	—

See accompanying notes to unaudited condensed consolidated financial statements.

ASTROTECH CORPORATION AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements (Unaudited)

(1) General Information

Description of the Company – Astrotech Corporation (Nasdaq: ASTC) (“Astrotech,” “the Company,” “we,” “us,” or “our”), a Delaware corporation organized in 1984, is a science and technology development and commercialization company that launches, manages, and builds scalable companies based on innovative technology in order to maximize shareholder value.

Basis of Presentation – The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the year ending June 30, 2020. These financial statements should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2019.

Our Business Units

Astrotech Technology, Inc.

There are a number of different market opportunities for the mass spectrometry technology that was originally developed by 1^st Detect Corporation (“1^st Detect”). Astrotech Technology, Inc. (“ATI”) was formed to own and license the intellectual property, which includes 37 patents granted with five additional patents in process, for different fields of use. ATI currently licenses the intellectual property to 1^st Detect for use in the security and detection market and to Agriculture Technology Corporation (“AG-TECH”) for use in the agriculture market.

1^st Detect Corporation

Agriculture Technology Corporation

AG-TECH, a licensee of ATI, has developed the AG-LAB-1000™ series of mass spectrometers for use in the agriculture market. The technology can detect trace levels of pesticides in agricultural products in real-time and it has garnered initial interest from the hemp and cannabis market. It can characterize and quantify the cannabinoids (including tetrahydrocannabinol (“THC”), cannabidiol (“CBD”), and many other constituents) and terpenes (aromatic oils) present in the plant or plant derivatives.

Astral Images Corporation

Astral Images Corporation (“Astral”) developed advanced film restoration and enhancement software. Although we believe Astral has developed valuable technology fortified by patents and trade secrets, the potential market has not yet evolved. Due to funding constraints, the Company’s primary focus remains on the pursuit of opportunities for its platform mass spectrometry technology. Consequently, headcount and expenditures at Astral have been minimized and new development is exclusively focused on strategic initiatives that would facilitate the realization of Astral’s value.

Accounting Pronouncements – In February 2016, the Financial Standards Accounting Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-02: Leases (“Topic 842” or “ASU 2016-02”) and ASU 2018-10: Codification Improvements to Topic 842, Leases (“ASU 2018-10”) which provide an additional (and optional) transition method whereby the new lease standard is applied at the adoption date and recognized as an adjustment to retained earnings. This ASU requires lessees to recognize a right-of-use (“ROU”) asset and lease liability on the balance sheet for all leases, with the exception of short-term leases. The asset will be based on the liability, subject to adjustment, such as for initial direct costs. For statement of operations purposes, leases are still required to be classified as either operating or financing. Operating leases will result in straight-line expense while financing leases will result in a front-loaded expense pattern.

On July 1, 2019, the Company adopted Topic 842 using the modified retrospective approach and the impact of the adoption of Topic 842 resulted in the recognition of an ROU asset and lease obligation on the Company’s condensed consolidated balance

sheets of approximately $1.6 million and an adjustment to retained earnings of $230 thousand. This application of the modified retrospective method will result in a balance sheet presentation that will not be comparable to the prior period in the first year of adoption. Results for reporting periods after July 1, 2019 are presented under Topic 842, while prior periods have not been adjusted. The Company elected the package of practical expedients permitted under the transition guidance within the new standard which, among other things, allowed the Company to carry forward the historical lease classifications. See Note 3 Leases for more information.

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. For assets held at amortized cost basis, ASU 2016-13 eliminates the probable initial recognition threshold in current generally accepted accounting standards, and, instead, requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For available-for-sale debt securities, credit losses should be measured in a manner similar to current generally accepted accounting standards; however, ASU 2016-13 will require that credit losses be presented as an allowance rather than as a write-down. ASU 2016-13 affects entities holding financial assets and net investment in leases that are not accounted for at fair value through net income. This amendment affects loans, debt securities, trade receivables, net investments in leases, off balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of this standard and does not believe it will have a material impact on its financial statements.

In August 2018, the FASB issued ASU 2018-13, “Fair Value measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”). ASU 2018-13 removes certain disclosure requirements, including the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. ASU 2018-13 also adds disclosure requirements, including changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements, and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. ASU 2018-13 is effective for annual reporting periods, and interim periods therein, beginning after December 15, 2019, with early adoption permitted. The amendments on changes in unrealized gains and losses, and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The Company does not expect the adoption of this guidance to have a material impact on its financial statements.

(2) Going Concern

Financial Condition

The Company’s consolidated financial statements for the three months ended September 30, 2019 have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of September 30, 2019, the Company has working capital of $0.4 million. The Company reported a net loss of $7.5 million for the fiscal year 2019 and a net loss of $2.1 million for the three months ended September 30, 2019, along with net cash used in operating activities of $8.5 million for the fiscal year 2019 and net cash used in operating activities of $1.8 million for the three months ended September 30, 2019. This raises substantial doubt about the Company’s ability to continue as a going concern.

Management’s Plans to Continue as a Going Concern

or as units comprised of one or more of the other securities. However, additional funding may not be available when needed or on terms acceptable to us. If we are unable to generate funding within a reasonable timeframe, we may have to delay, reduce or terminate our research and development programs, limit strategic opportunities, or curtail our business activities. Astrotech’s consolidated financial statements as of September 30, 2019 do not include any adjustments that might result from the outcome of this uncertainty.

(3) Leases

As of July 1, 2019, the Company adopted Topic 842, using the modified retrospective method of adoption. Astrotech elected to use the transition option that allows the Company to initially apply the new lease standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the year of adoption. Comparable periods continue to be presented under the guidance of the previous standard, Accounting Standards Codification (“ASC”) Topic 840. Topic 842 requires lessees to recognize a lease liability and ROU asset on the balance sheet for operating leases. The adoption of Topic 842 resulted in an adjustment to retained earnings of $230 thousand.

The Company has two existing facility leases and several small equipment leases. Astrotech leases office space consisting of 5,219 square feet in Austin, Texas and houses executive management, finance and accounting, and marketing and communications. The lease began in November 2016 and expires in December 2023 with a provision to renew and extend the lease for the entire premises for one renewal term of five years. Astrotech must, in writing, advise the landlord of its intention to renew the lease at least eight months before the expiration of its current lease in order to renew the lease. In May 2013, 1^st Detect completed build-out of a 16,540 square foot leased research and development and production facility in Webster, Texas. This facility is equipped with state-of-the-art laboratories, a clean room, a production shop, and offices for staff. The term of the lease is 62 months and includes options to extend for two additional five-year periods. In February 2015, 1^st Detect exercised its right of first refusal on the adjoining space of 9,138 square feet. The original lease began in May 2013 and was to expire in June 2018; these dates were amended in October 2014 with the amended lease beginning February 1, 2015, and expiring April 30, 2020, with provisions to renew and extend the lease for the entire premises, but not less than the entire premises, for two renewal terms of five years each. On June 1, 2018, the Company entered into its third amendment of the original lease removing 8,118 square feet from its leased space, leaving leased premises with a total square footage of 17,560. The Company included the assumption that 1^st Detect will occupy comparable space to its current location with a new five-year lease in its calculations for adopting Topic 842. The Company has not entered into any financing leases.

Operating lease assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate used at adoption was 11%. Significant judgement is required when determining the Company’s incremental borrowing rate. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

The condensed consolidated balance sheet classification of lease assets and liabilities are as follows:

(In thousands)
Assets	September 30, 2019
Operating lease right-of-use assets, beginning balance	$	1,608
Current period amortization		(81	)
Total operating lease right-of-use asset	$	1,527

(In thousands)
Liabilities	September 30, 2019
Operating lease liabilities - current	$	237
Operating lease liabilities - non-current		1,304
Total lease liabilities	$	1,541

Future minimum lease payments as of September 30, 2019 under non-cancellable operating leases are as follows:

(In thousands)
For the Year Ended June 30,	September 30, 2019
2020	$	292
2021		414
2022		425
2023		434
2024		258
Thereafter		188
Total lease payments		2,011
Less: imputed interest		470
Operating lease liability		1,541
Less: operating lease liabilities - current		237
Operating lease liabilities - non-current	$	1,304

Cash payments for operating leases for the three months ended September 30, 2019 totaled $96 thousand. The weighted-average remaining lease term for operating leases is 5.1 years.

(4) Stockholders’ Equity

A prospectus relating to the ATM Offering was filed with the SEC on November 9, 2018. Since its filing, as of September 30, 2019, the Company has sold 360,668 shares of common stock pursuant to an At the Market Issuance Sales Agreement with B. Riley FBR, under which B. Riley FBR acts as sales agent. In connection with the sale of these shares of common stock, the Company has received net proceeds of $1.4 million. The weighted-average sale price per share was $3.80.

The Company’s stockholders’ equity as of September 30, 2019 was less than $2.5 million, which is less than the requirement under Nasdaq Listing Rule 5550(b)(1) for continued listing on The Nasdaq Capital Market. As a result, though no assurance can be given, the Company anticipates that Nasdaq will provide notice of this development and require the Company to take steps in order to avoid the delisting of its common stock.

(5) Net Loss per Share

Basic net loss per share is computed on the basis of the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed based on the weighted average number of common shares outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method and the if-converted method. Potentially dilutive common shares include outstanding stock options and share-based awards.

The following table reconciles the numerators and denominators used in the computations of both basic and diluted net loss per share:

	Three Months Ended September 30,
(In thousands, except per share data)	2019			2018
Numerator:
Net loss	$	(2,068	)	$	(2,238	)
Denominator:
Denominator for basic and diluted net loss per share — weighted average common stock outstanding		5,591			4,073
Basic and diluted net loss per common share:
Net loss	$	(0.37	)	$	(0.55	)

All unvested restricted stock awards for the three months ended September 30, 2019 are not included in diluted net loss per share, as the impact to net loss per share would be anti-dilutive. Options to purchase 324,153 shares of common stock at exercise prices ranging from $2.83 to $8.35 per share outstanding as of September 30, 2019 were not included in diluted net loss per share, as the impact to net loss per share would be anti-dilutive.

(6) Revenue Recognition

fiscal year 2019. The methodology used is based on contract type and how products and services are provided. The guidelines of Topic 606 establish a five-step process to govern the recognition and reporting of revenue from contracts with customers. The five steps are: (i) identify the contract with a customer, (ii) identify the performance obligations within the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations within the contract, and (v) recognize revenue when or as the performance obligations are satisfied.

An additional factor is reasonable assurance of collectability. This necessitates deferral of all or a portion of revenue recognition until collection. During the three months ended September 30, 2019, the Company had one revenue source and revenue was recognized at a point in time consistent with the guidelines in Topic 606.

(7) Fair Value Measurement

The accounting standard for fair value measurements defines fair value, establishes a market-based framework or hierarchy for measuring fair value, and expands disclosures about fair value measurements. The standard is applicable whenever assets and liabilities are measured and included in the financial statements at fair value.

The fair value hierarchy established in the standard prioritizes the inputs used in valuation techniques into three levels as follows:

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 - Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities.

As of September 30, 2019, the fair value of the Company’s cash and cash equivalents approximate their carrying value due to their short-term nature.

(8) Term Note Payable – Related Party

On September 5, 2019, the Company entered into a private placement transaction with Thomas B. Pickens III, the Chief Executive Officer and Chairman of the Board of Directors of the Company for the issuance and sale of a secured promissory note (“the Note”) to Mr. Pickens with a principal amount of $1.5 million. Interest on the Note shall accrue at 11% per annum. The principal amount and accrued interest on the Note shall become due and payable on September 5, 2020 (the “Maturity Date”). The Company may prepay the principal amount and all accrued interest on the Note at any time prior to the Maturity Date. In connection with the issuance of the Note, the Company, along with 1^st Detect Corporation and Astrotech Technologies, Inc. (the “Subsidiaries”), entered into a security agreement, dated as of September 5, 2019, with Mr. Pickens (the “Security Agreement”), pursuant to which the Company and the Subsidiaries granted to Mr. Pickens a security interest in all of the Company’s and the Subsidiaries’ Collateral, as such term is defined in the Security Agreement. In addition, the Subsidiaries jointly and severally agreed to guarantee and act as surety for the Company’s obligation to repay the Note pursuant to a subsidiary guarantee (the “Subsidiary Guarantee”).

(9) Business Risk and Credit Risk Concentration Involving Cash

The Company maintains funds in bank accounts that may exceed the limit insured by the Federal Deposit Insurance Corporation of $250 thousand per depositor. The risk of loss attributable to these uninsured balances is mitigated by depositing funds in what we believe to be high credit quality financial institutions. The Company has not experienced any losses in such accounts.

(10) Common Stock Compensation

Stock Option Activity Summary

The Company’s stock option activity for the three months ended September 30, 2019, is as follows:

	Shares (in thousands)		Weighted Average Exercise Price
Outstanding at June 30, 2019		324	$	5.71
Granted		—		—
Exercised		—		—
Canceled or expired		—		—
Outstanding at September 30, 2019		324	$	5.71

The aggregate intrinsic value of options exercisable at September 30, 2019, was $0, as the fair value of the Company’s common stock is less than the exercise prices of these options. The remaining stock-based compensation expense of $106 thousand related to stock options will be recognized over a weighted-average period of 0.61 years.

The table below details the Company’s stock options outstanding as of September 30, 2019:

Range of exercise prices	Number Outstanding		Options Outstanding Weighted- Average Remaining Contractual Life (years)		Weighted- Average Exercise Price		Number Exercisable		Options Exercisable Weighted- Average Exercise Price
$2.83 – 3.55		70,500		2.73	$	3.39		70,500	$	3.39
$5.30 – 5.85		123,653		7.61		5.48		79,575		5.48
$6.00 – 8.35		130,000		5.15		7.19		86,000		6.59
$2.83 – 8.35		324,153		5.56	$	5.71		236,075	$	5.26

Compensation costs recognized related to stock option awards were $44 thousand and $41 thousand for the three months ended September 30, 2019, and 2018.

Restricted Stock

The Company’s restricted stock activity for the three months ended September 30, 2019, is as follows:

	Shares (in thousands)			Weighted Average Grant-Date Fair Value
Outstanding at June 30, 2019		208		$	4.06
Granted		5			2.47
Vested		(4	)		8.88
Canceled or expired		—			—
Outstanding at September 30, 2019		209		$	3.81

Stock compensation expenses related to restricted stock were $60 thousand and ($5) thousand for the three months ended September 30, 2019, and 2018. The remaining stock-based compensation expense of $496 thousand related to restricted stock awards granted will be recognized over a weighted-average period of 2.17 years.

(11) Income Taxes

The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. Valuation allowances are established, when necessary, to reduce deferred tax assets to amounts that are more likely than not to be realized. As of September 30, 2019, the Company established a valuation allowance against all of its net deferred tax assets.

For the three months ended September 30, 2019 and 2018, the Company incurred pre-tax losses in the amount of $2.1 million and $2.2 million, respectively. The total effective tax rate was approximately 0% for the each of the three months ended September 30, 2019 and 2018.

For the each of the three months ended September 30, 2019 and 2018, the Company’s effective tax rate differed from the federal statutory rate of 21%, primarily due to the valuation allowance placed against its net deferred tax assets.

The Tax Cuts and Jobs Act was enacted on December 22, 2017 and provides for a refundable credit of any AMT previously paid. The AMT credit receivable by the Company of $857 thousand for AMT previously paid will be refunded subsequent to the filing of returns for fiscal years ending June 30, 2019, June 30, 2020, June 30, 2021 and June 30, 2022. Credit amounts calculated for such years are $429 thousand, $214 thousand, $107 thousand, and $107 thousand, respectively.

FASB ASC 740, “Income Taxes” addresses the accounting for uncertainty in income tax recognized in an entity’s financial statements and prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken or expected to be taken on a tax return. The Company had no unrecognized tax benefit for the three months ended September 30, 2019 or 2018.

Loss carryovers are generally subject to modification by tax authorities until three years after they have been utilized; as such, the Company is subject to examination for the fiscal years ended 2000 through present for federal purposes and fiscal years ended 2006 through present for state purposes. The reason for this extended examination period is due to the utilization of the loss carryovers generated by the sale of our Astrotech Space Operations business unit in fiscal year 2015.

(12) Commitments and Contingencies

The Company is subject to various lawsuits and other claims in the normal course of business. In addition, from time to time, the Company receives communications from government or regulatory agencies concerning investigations or allegations of noncompliance with laws or regulations in jurisdictions in which the Company operates.

The Company establishes reserves for the estimated losses on specific contingent liabilities, for regulatory and legal actions where the Company deems a loss to be probable and the amount of the loss can be reasonably estimated. In other instances, the Company is not able to make a reasonable estimate of liability because of the uncertainties related to the outcome or the amount or range of potential loss.

Litigation, Investigations, and Audits – We are not party to, nor are our properties the subject of, any material pending legal proceedings.

(13) Segment Information

The Company currently has one reportable business unit: 1^st Detect Corporation. In prior periods, the Company had two reportable business units: 1^st Detect Corporation and Astral Images Corporation. As of September 30, 2019, Astral no longer meets the criteria for segment reporting as both its assets and operations are minimal. For more information on key financial metrics of the Company’s segments in prior reporting periods, refer to the Company’s Annual Report on Form 10-K for the year ended June 30, 2019.

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact are forward-looking statements for purposes of federal and state securities laws. Forward-looking statements may include the words “may,” “will,” “plans,” “believes,” “estimates,” “expects,” “intends,” and other similar expressions. Such statements are subject to risks and uncertainties that could cause our actual results to differ materially from those projected in the statements. Such risks and uncertainties include, but are not limited to:

•

Our ability to raise sufficient capital to meet our long- and short-term liquidity requirements;

•

Our ability to continue as a going concern;

•

The effect of economic and political conditions in the United States or other nations that could impact our ability to sell our products and services or gain customers;

•

Product demand and market acceptance risks, including our ability to develop and sell products and services to be used by governmental or commercial customers;

•

The impact of trade barriers imposed by the U.S. government, such as import/export duties and restrictions, tariffs and quotas, and potential corresponding actions by other countries in which the Company conducts its business;

•

Our ability to successfully pursue our business plan and execute our strategy;

•

Technological difficulties and potential legal claims arising from any technological difficulties;

•

Uncertainty in government funding and support for key programs, grant opportunities, or procurements;

•

The impact of competition on our ability to win new contracts; and

•

Our ability to meet technological development milestones and overcome development challenges.

Although we believe that the assumptions underlying our forward-looking statements are reasonable, any of the assumptions could be inaccurate; therefore, we cannot assure you that the forward-looking statements included in this Quarterly Report on Form 10-Q will prove to be accurate. In light of the significant uncertainties inherent in our forward-looking statements, the inclusion of such information should not be regarded as a representation by us or any other person that our objectives and plans will be achieved. Some of these and other risks and uncertainties that could cause actual results to differ materially from such forward-looking statements are more fully described in our 2019 Annual Report on Form 10-K, elsewhere in this Quarterly Report on Form 10-Q, or in the documents incorporated by reference herein. Except as may be required by applicable law, we undertake no obligation to publicly update or advise of any change in any forward-looking statement, whether as a result of new information, future events, or otherwise. In making these statements, we disclaim any obligation to address or update each factor in future filings with the Securities and Exchange Commission (“SEC”) or communications regarding our business or results, and we do not undertake to address how any of these factors may have caused changes to discussions or information contained in previous filings or communications. In addition, any of the matters discussed above may have affected our past results and may affect future results, so that our actual results may differ materially from those expressed in this Quarterly Report on Form 10-Q and in prior or subsequent communications.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following information should be read in conjunction with the unaudited condensed consolidated financial statements and the accompanying notes included in Part I, Item 1 of this Report.

Business Overview

Astrotech Corporation (Nasdaq: ASTC) (“Astrotech,” the “Company,” “we,” “us,” or “our”), a Delaware corporation organized in 1984, is a science and technology development and commercialization company that launches, manages, and builds scalable companies based on innovative technology in order to maximize shareholder value.

The Company’s efforts are focused on commercializing its platform mass spectrometry technology through its wholly-owned subsidiaries:

•

Astrotech Technology, Inc. (“ATI”) owns and licenses the intellectual property related to our mass spectrometry technology.

•

1^st Detect Corporation (“1^st Detect”) is a manufacturer of explosives and narcotics trace detectors developed for use at airports, secured facilities, and borders worldwide.

•

Agriculture Technology Corporation (“AG-TECH”) is a manufacturer of mass spectrometers for use in the agriculture market.

Our Business Units

Astrotech Technology, Inc.

There are a number of different market opportunities for the mass spectrometry technology that was originally developed by 1^st Detect. ATI was formed to own and license the intellectual property, which includes 37 patents granted with five additional patents in process, for different fields of use. ATI currently licenses the intellectual property to 1^st Detect for use in the security and detection market and to AG-TECH for use in the agriculture market.

1^st Detect Corporation

1^st Detect, a licensee of ATI, has developed the TRACER 1000™, the world’s first certified mass spectrometer (“MS”)-based explosives trace detector (“ETD”), designed to replace the explosives and narcotics trace detectors used at airports, secured facilities, and borders worldwide. We believe that government and airport customers are unsatisfied with the currently deployed ETD technology, which is driven by an antiquated technology known as Ion Mobility Spectrometry (“IMS”). We believe that IMS-based ETDs are fraught with false positives, as they often misidentify personal care products and other common household chemicals as explosives, causing unnecessary passenger delays and frustration, significant wasted security resources, and lack of security personnel confidence in ETDs. In addition, there are hundreds of different types of explosives, but IMS-based ETDs have a very limited threat detection library reserved only for those several explosives of largest concern. Adding additional compounds to the detection library of an IMS-based ETD fundamentally reduces the instrument’s performance further, increasing the likelihood of false alarms. In contrast, adding additional compounds does not degrade the TRACER 1000’s detection capabilities, as it has a virtually unlimited and easily expandable threat library. With terrorist threats becoming more numerous, sophisticated, and lethal, security professionals have been looking for better instrumentation to address the evolving threats.

MS has historically been reserved for highly trained professionals in high-end laboratories with large budgets. 1^st Detect has overcome the significant challenge of making this sophisticated MS technology powerful, yet simple to use, with an easy-to-understand red light or green light output, at a price that is competitive with IMS. In addition to an increased probability of detection, decreased false alarm rate, and a virtually unlimited threat library that is field-upgradable, we believe that the 1^st Detect ETD can increase passenger throughput and save billions of dollars in wasted airport security personnel resources. With more than 30,000 IMS instruments installed in the field, many of which are nearing their end of life or are unable to be updated to the newest standards, 1^st Detect is positioned to be a leader in securing worldwide checkpoints.

Either Transportation Security Administration (“TSA”) or European Civil Aviation Conference (“ECAC”) certification is necessary to sell the TRACER 1000 to the airport market and the TRACER 1000 received ECAC certification on February 21, 2019 for both passenger and cargo screening. On June 26, 2019, the Company announced the official launch of the TRACER 1000. As the TRACER 1000 is the first MS-based ETD to have ever passed either U.S. or European regulatory testing, there

has been considerable interest from prospective customers, which has yielded a number of successful demonstrations and field trials.

In addition, on March 27, 2018, the Company announced that the TRACER 1000 was accepted into TSA’s Air Cargo Screening Technology Qualification Test (“ACSQT”) and, on April 4, 2018, the Company announced that the TRACER 1000 was beginning testing with TSA for passenger screening at airports. With similar protocols as ECAC testing, we have received positive feedback under both programs, as anticipated, and both programs continue to progress as expected; however, there is no assurance that the TRACER 1000 will be approved by TSA for either cargo or passenger screening.

Agriculture Technology Corporation

AG-TECH, a licensee of ATI, has developed the AG-LAB-1000™ series of mass spectrometers for use in the agriculture market. We believe our technology is perfectly suited for the agriculture market where the AG-LAB 1000 is being designed to identify trace levels of pesticides and other chemical constituents, including the chemical make-up of the plant, in real-time. Competing technologies require samples to be sent to a laboratory for analysis, which can take five to eight days for the results.

With the increasing number of U.S. states and countries legalizing hemp and cannabis, pesticide regulations have become increasingly more important. In addition to detecting pesticides, the AG-LAB-1000 instrumentation can characterize and quantify the cannabinoids (including tetrahydrocannabinol (“THC”), cannabidiol (“CBD”), and many other constituents) and terpenes (aromatic oils) present in hemp and cannabis. This information can be used by growers, distributors, and retailers to customize products, to ensure quality control, or to verify delivered products match the order. It can also be used by regulators and law enforcement to track and trace products or to ensure THC levels are under the legal limit set forth by the 2018 Farm Bill, which made hemp containing less than 0.3% THC legal in the United States.

Astral Images Corporation

Astral Images (“Astral”) developed advanced film restoration and enhancement software. Although we believe Astral has developed valuable technology fortified by patents and trade secrets, the potential market has not advanced as quickly as anticipated. Due to funding constraints, the Company’s primary focus remains on the pursuit of opportunities for its platform mass spectrometry technology. Consequently, headcount and expenditures at Astral have been minimized and new development is exclusively focused on strategic initiatives that would facilitate the realization of Astral’s value.

Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”). The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Estimates and assumptions are reviewed periodically. Actual results may differ from these estimates under different assumptions or conditions.

As of July 1, 2019, the Company adopted ASU 2016-02, Leases (“Topic 842”) using the modified retrospective method of adoption. Astrotech elected to use the transition option that allows the Company to initially apply the new lease standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the year of adoption. Comparable periods continue to be presented under the guidance of the previous standard, Accounting Standards Codification (“ASC”) Topic 840. Topic 842 requires lessees to recognize a lease liability and right-of-use asset on the balance sheet for operating leases. The adoption of Topic 842 resulted in an adjustment to retained earnings of $230 thousand.

Results of Operations

Three months ended September 30, 2019, compared to three months ended September 30, 2018:

Selected consolidated financial data for the quarters ended September 30, 2019, and 2018 is as follows:

	Three Months Ended September 30,
(In thousands)	2019			2018
Revenue	$	1		$	33
Cost of revenue		—			11
Gross profit		1			22
Gross margin		100	%		67	%
Operating expenses:
Selling, general and administrative		1,202			1,144
Research and development		855			1,103
Total operating expenses		2,057			2,247
Loss from operations		(2,056	)		(2,225	)
Interest and other expense, net		(12	)		(13	)
Income tax benefit		—			—
Net loss	$	(2,068	)	$	(2,238	)

Revenue – Total revenue decreased $32 thousand during the first quarter of fiscal 2020, compared to the first quarter of fiscal 2019. All of the revenue generated in the first quarter of fiscal 2020 was associated with the sale of materials related to prior iterations of our MS technology. All of the revenue generated in the first quarter of fiscal 2019 was associated with the Company’s now-discontinued agreement between Astral and ColorTime, a post-production house specializing in media content creation, restoration, and distribution.

Cost of Revenue – Gross profit is comprised of revenue less cost of revenue. In the first quarter of fiscal 2019, cost of revenue was comprised of labor related to the agreement with ColorTime. No such costs were recognized during the first quarter of fiscal 2020.

Operating Expenses – Operating expenses decreased $190 thousand, or 8%, during the first quarter of fiscal 2020, compared to the first quarter of fiscal 2019. Selling, general and administrative increased $58 thousand, or 5%, due to an increase in equity compensation from a grant issued in the second quarter of fiscal 2019. Research and development decreased $248 thousand, or 22%, during the first quarter of fiscal 2020, compared to the first quarter of fiscal 2019. In the first quarter of fiscal 2019, we were focusing on the development of the TRACER 1000, whereas now we are preparing for the production and sale of the TRACER 1000 to the international airport security market.

Income Taxes – Income tax benefit did not change during the first quarter of fiscal 2020, compared to the first quarter of fiscal 2019. The realization of tax benefits depends on the existence of future taxable income. Pursuant to ASC 740 “Income Taxes” (“ASC 740”), a valuation allowance has been established on all the Company’s deferred tax assets.

Liquidity and Capital Resources

The following is a summary of the change in our cash and cash equivalents:

	Three Months Ended September 30,
(In thousands)	2019			2018			Change
Change in cash and cash equivalents:
Net cash used in operating activities	$	(1,830	)	$	(2,247	)	$	417
Net cash provided by investing activities		—			3,595			(3,595	)
Net cash provided by financing activities		1,821			6			1,815
Net change in cash and cash equivalents	$	(9	)	$	1,354		$	(1,363	)

Cash and Cash Equivalents

As of September 30, 2019, we held cash and cash equivalents of $1.6 million, and our working capital was approximately $0.4 million. As of June 30, 2019, we had cash and cash equivalents of $1.6 million, and our working capital was approximately $1.9 million. Cash and cash equivalents remained consistent as of September 30, 2019, compared to June 30, 2019, due to a

note payable from a related party and the sale of shares of common stock through an “at the market offering” program (the “ATM Offering”), offset by funding our normal operating activities and research and development initiatives.

Operating Activities

Cash used in operating activities decreased $0.4 million for the three months ended September 30, 2019, compared to the three months ended September 30, 2018, primarily due to a reduction in our expenses.

Investing Activities

Cash provided by investing activities decreased $3.6 million for the three months ended September 30, 2019, compared to the three months ended September 30, 2018, due to liquidating our available-for-sale investments in the first quarter of fiscal 2019.

Financing Activities

Cash provided by financing activities increased $1.8 million for the three months ended September 30, 2019, compared to the three months ended September 30, 2018, due to a note payable from a related party as well as the sale of shares of common stock through the ATM Offering.

Liquidity

As of September 30, 2019, we had cash and cash equivalents of $1.6 million, and our working capital was approximately $0.4 million. For the fiscal year 2019, the Company reported a net loss of $7.5 million and net cash used in operating activities of $8.5 million. For the three months ended September 30, 2019, the Company reported a net loss of $2.1 million and net cash used in operating activities of $1.8 million. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

The Company remains resolute in identifying the optimal solution to its liquidity issue. The Company is currently evaluating several potential sources for additional liquidity. These include, but are not limited to, selling the Company or a portion thereof, selling a license to some of our technology, debt financing, equity financing, merging, or engaging in a strategic partnership. On July 3, 2018, management filed Form S-3 to raise funds through the capital markets. On October 9, 2018, the Company entered into a Securities Purchase Agreement (the “Agreement No. 1”) with Thomas B. Pickens III, the Chief Executive Officer and Chairman of the Board of Directors of the Company, and a long-term accredited investor in the Company (the “Investor”). Pursuant to Agreement No. 1, the Company agreed to sell an aggregate of 866,950 shares of its series B convertible preferred stock, par value $0.001 per share (the “Series B Preferred Shares”) to Mr. Pickens and 409,645 of its shares of common stock, par value $0.001 per share (the “Common Shares”) to the Investor, at a price per share of $2.35 and for aggregate gross proceeds of approximately $3.0 million. The purchase price of $2.35 per share was equal to the closing price on The NASDAQ Capital Market on October 8, 2018. The Series B Preferred Shares converted into an aggregate of 866,950 shares of common stock on December 7, 2018 upon receipt of shareholder approval in accordance with NASDAQ Listing Rule 5635(b). On April 17, 2019, the Company entered into another Securities Purchase Agreement (the “Agreement No. 2”) with Mr. Pickens and the Investor. Pursuant to Agreement No. 2, the Company agreed to sell an aggregate of 280,898 shares of its series C convertible preferred stock, par value $0.001 per share (the “Series C Preferred Shares”) to the Investor and 280,898 of its series D convertible preferred stock, par value $0.001 per share (the “Series D Preferred Shares”) to Mr. Pickens, at a price per share of $3.56 and for aggregate gross proceeds of approximately $2.0 million. The purchase price of $3.56 per share was equal to the closing consolidated bid price on The NASDAQ Capital Market on April 16, 2019. The holder of the Series C Preferred Shares has agreed to restrict its ability to convert the Series C Preferred Shares such that the number of shares of the Company’s common stock held by such holder and its affiliates after such conversion does not exceed 9.99% of the Company’s then issued and outstanding shares of common stock. The Series D Preferred Shares are convertible into an aggregate of 280,898 shares of common stock at the option of the holder. On September 5, 2019, the Company entered into a private placement transaction with Mr. Pickens for the issuance and sale a secured promissory note to Mr. Pickens with a principal amount of $1.5 million. As of September 30, 2019, the Company has sold 360,668 shares of common stock pursuant to an At the Market Issuance Sales Agreement with B. Riley FBR through the ATM Offering under which B. Riley FBR acts as sales agent. A prospectus relating to the ATM Offering was filed with the SEC on November 9, 2018. In connection with the sale of these shares of common stock, the Company has received net proceeds of $1.4 million. The weighted-average sale price per share was $3.80.

The Company is currently evaluating potential offerings of any combination of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock or debt securities, or any combination of the foregoing, either individually or as units comprised of one or more of the other securities. However, additional funding may not be available when needed or

on terms acceptable to us. If we are unable to generate funding within a reasonable timeframe, we may have to delay, reduce or terminate our research and development programs, limit strategic opportunities, or curtail our business activities. Astrotech’s consolidated financial statements as of September 30, 2019 do not include any adjustments that might result from the outcome of this uncertainty.

Income Taxes

Off-Balance Sheet Arrangements

We did not have any off-balance sheet arrangements as of September 30, 2019, or June 30, 2019.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable to smaller reporting companies.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as of the end of the period covered by this Quarterly Report. Based on the evaluation and criteria of these disclosure controls and procedures, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting during the three months ended September 30, 2019 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II: OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

As of September 30, 2019, we are not involved in any pending or threatened legal proceedings that we believe could reasonably be expected to have a material adverse effect on our financial condition, results of operations, or cash flows. From time to time, we are subject to legal proceedings and business disputes involving ordinary routine legal matters and claims incidental to our business. The ultimate legal and financial liability with respect to such matters generally cannot be estimated with certainty and requires the use of estimates in recording liabilities for potential litigation settlements or awards against us. Estimates for losses from litigation are made after consultation with outside counsel. If estimates of potential losses increase or the related facts and circumstances change in the future, we may be required to record either more or less litigation expense.

ITEM 1A. RISK FACTORS

Not applicable to smaller reporting companies.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURE

Not applicable.

ITEM 5. OTHER INFORMATION

The Company anticipates that the date of its 2019 annual stockholder meeting will be more than 30 calendar days after the date of the Company’s 2018 annual stockholder meeting, but has not made a final determination as to such date. Once available, the Company will file a Current Report on Form 8-K to (i) announce the date of the Company’s 2019 annual stockholder meeting; and (ii) to disclose the deadline for the submission of shareholder proposals for the 2019 annual stockholder meeting pursuant to SEC Rule 14a-8, which date shall be a reasonable time before the Company mails its proxy materials for its 2019 annual stockholder meeting.

ITEM 6. EXHIBITS

The following exhibits are filed herewith:

Exhibit No.	Description	Incorporation by Reference

4.1	Promissory Note due September 5, 2020.	Exhibit 4.1 to Form 8-K filed on September 11, 2019

10.1	Security Agreement, dated September 5, 2019, by and among the Company, certain of the Company’s subsidiaries and Thomas B. Pickens III.	Exhibit 10.1 to Form 8-K filed on September 11, 2019

10.2	Subsidiary Guarantee, dated September 5, 2019, made by certain of the Company’s subsidiaries in favor of Thomas B. Pickens III.	Exhibit 10.2 to Form 8-K filed on September 11, 2019

31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.	Filed herewith.

31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.	Filed herewith.

32.1	Certification pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934.	Filed herewith.

101	The following financial information from the Company’s Quarterly Report on Form 10-Q, for the period ended September 30, 2019 formatted in eXtensible Business Reporting Language: (i) Unaudited Condensed Consolidated Balance Sheets, (ii) Unaudited Condensed Consolidated Statements of Operations, (iii) Unaudited Condensed Consolidated Statements of Cash Flows, (iv) Notes to Unaudited Condensed Consolidated Financial Statements.	Filed herewith.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		Astrotech Corporation



Date: November 14, 2019		/s/ Eric Stober
		Eric Stober
		Chief Financial Officer and Principal Accounting Officer

EX-31.1 2 astc-ex311_7.htm EX-31.1 astc-ex311_7.htm

Exhibit 31.1

Certification of Chief Executive Officer

Section 302 Certification

I, Thomas B. Pickens III, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Astrotech Corporation;

Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 14, 2019	/s/ Thomas B. Pickens III
	Thomas B. Pickens III
	Chief Executive Officer

EX-31.2 3 astc-ex312_6.htm EX-31.2 astc-ex312_6.htm

Exhibit 31.2

Certification of Chief Financial Officer

Section 302 Certification

I, Eric Stober, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Astrotech Corporation;

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Date: November 14, 2019	/s/ Eric Stober
	Eric Stober
	Chief Financial Officer

EX-32.1 4 astc-ex321_8.htm EX-32.1 astc-ex321_8.htm

Exhibit 32.1

Certification Pursuant to 18 U.S.C. Section 1350,

as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Thomas B. Pickens III, the Chief Executive Officer, and Eric Stober, the Chief Financial Officer, of Astrotech Corporation (the “Company”), hereby certify, that, to their knowledge:

The Quarterly Report on Form 10-Q for the period ended September 30, 2019 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or 15 (d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: November 14, 2019

	/s/ Thomas B. Pickens III
	Thomas B. Pickens III
	Chief Executive Officer

	/s/ Eric Stober
	Eric Stober
	Chief Financial Officer

GRAPHIC 5 gvbsmgzd01dr000002.jpg GRAPHIC begin 644 gvbsmgzd01dr000002.jpg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end GRAPHIC 6 gvbsmgzd01dr000001.jpg GRAPHIC begin 644 gvbsmgzd01dr000001.jpg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astc-20190930.xml XBRL INSTANCE DOCUMENT xbrli:shares iso4217:USD iso4217:USD xbrli:shares astc:Patent utr:sqft astc:renewal_term xbrli:pure astc:segment 0001001907 2019-07-01 2019-09-30 0001001907 2019-11-08 0001001907 2019-09-30 0001001907 2019-06-30 0001001907 us-gaap:ConvertiblePreferredStockMember 2019-09-30 0001001907 us-gaap:ConvertiblePreferredStockMember 2019-06-30 0001001907 us-gaap:SeriesCPreferredStockMember 2019-09-30 0001001907 us-gaap:SeriesCPreferredStockMember 2019-06-30 0001001907 us-gaap:SeriesDPreferredStockMember 2019-09-30 0001001907 us-gaap:SeriesDPreferredStockMember 2019-06-30 0001001907 2018-07-01 2018-09-30 0001001907 astc:SeriesCConvertiblePreferredStockMember 2019-06-30 0001001907 astc:SeriesDConvertiblePreferredStockMember 2019-06-30 0001001907 us-gaap:CommonStockMember 2019-06-30 0001001907 us-gaap:TreasuryStockMember 2019-06-30 0001001907 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001001907 us-gaap:RetainedEarningsMember 2019-06-30 0001001907 us-gaap:RetainedEarningsMember us-gaap:AccountingStandardsUpdate201602Member 2019-07-01 2019-09-30 0001001907 us-gaap:AccountingStandardsUpdate201602Member 2019-07-01 2019-09-30 0001001907 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0001001907 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001001907 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001001907 astc:SeriesCConvertiblePreferredStockMember 2019-09-30 0001001907 astc:SeriesDConvertiblePreferredStockMember 2019-09-30 0001001907 us-gaap:CommonStockMember 2019-09-30 0001001907 us-gaap:TreasuryStockMember 2019-09-30 0001001907 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001001907 us-gaap:RetainedEarningsMember 2019-09-30 0001001907 us-gaap:CommonStockMember 2018-06-30 0001001907 us-gaap:TreasuryStockMember 2018-06-30 0001001907 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001001907 us-gaap:RetainedEarningsMember 2018-06-30 0001001907 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001001907 2018-06-30 0001001907 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-09-30 0001001907 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0001001907 us-gaap:CommonStockMember 2018-07-01 2018-09-30 0001001907 us-gaap:TreasuryStockMember 2018-07-01 2018-09-30 0001001907 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0001001907 us-gaap:CommonStockMember 2018-09-30 0001001907 us-gaap:TreasuryStockMember 2018-09-30 0001001907 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001001907 us-gaap:RetainedEarningsMember 2018-09-30 0001001907 2018-09-30 0001001907 us-gaap:AccountingStandardsUpdate201602Member 2018-07-01 2018-09-30 0001001907 us-gaap:AccountingStandardsUpdate201602Member 2019-07-01 0001001907 2018-07-01 2019-06-30 0001001907 2018-10-09 2018-10-09 0001001907 2019-04-17 2019-04-17 0001001907 2018-11-09 2019-09-30 0001001907 astc:SecuredPromissoryNoteMember us-gaap:PrivatePlacementMember 2019-09-05 0001001907 astc:AustinTexasMember 2016-11-30 0001001907 astc:AustinTexasMember 2016-11-01 2016-11-30 0001001907 astc:ResearchAndDevelopmentAndProductionFacilityMember astc:WebsterTexasMember astc:FirstDetectCorporationMember 2013-05-31 0001001907 astc:ResearchAndDevelopmentAndProductionFacilityMember astc:WebsterTexasMember astc:FirstDetectCorporationMember 2013-05-01 2013-05-31 0001001907 astc:FirstDetectCorporationMember 2014-10-01 2014-10-31 0001001907 astc:FirstDetectCorporationMember 2015-02-28 0001001907 astc:FirstDetectCorporationMember 2014-10-31 0001001907 astc:WebsterTexasMember 2018-06-01 0001001907 2019-07-01 0001001907 2019-07-02 2019-09-30 0001001907 astc:MarketIssuanceSalesAgreementMember us-gaap:CommonStockMember 2018-11-09 2019-09-30 0001001907 srt:MaximumMember 2019-09-30 0001001907 astc:SecuredPromissoryNoteMember us-gaap:PrivatePlacementMember 2019-09-04 2019-09-05 0001001907 astc:ExercisePriceRangeOneMember 2019-07-01 2019-09-30 0001001907 astc:ExercisePriceRangeTwoMember 2019-07-01 2019-09-30 0001001907 astc:ExercisePriceRangeThreeMember 2019-07-01 2019-09-30 0001001907 astc:ExercisePriceRangeOneMember 2019-09-30 0001001907 astc:ExercisePriceRangeTwoMember 2019-09-30 0001001907 astc:ExercisePriceRangeThreeMember 2019-09-30 0001001907 us-gaap:EmployeeStockOptionMember 2019-07-01 2019-09-30 0001001907 us-gaap:EmployeeStockOptionMember 2018-07-01 2018-09-30 0001001907 us-gaap:RestrictedStockMember 2019-06-30 0001001907 us-gaap:RestrictedStockMember 2019-07-01 2019-09-30 0001001907 us-gaap:RestrictedStockMember 2019-09-30 0001001907 us-gaap:RestrictedStockMember 2018-07-01 2018-09-30 0001001907 srt:ScenarioForecastMember 2019-07-01 2020-06-30 0001001907 srt:ScenarioForecastMember 2020-07-01 2021-06-30 0001001907 srt:ScenarioForecastMember 2021-07-01 2022-06-30 ASTROTECH Corp 0001001907 ASTC --06-30 Non-accelerated Filer true false 10-Q 2019-09-30 2020 Q1 false 5915129 Yes false 001-34426 91-1273737 201 West 5th Street Suite 1275 Austin TX 78701 512 485-9530 Yes Common Stock, $0.001 par value per share NASDAQ DE true false

1579000

1588000

3000

121000

150000

209000

181000

643000

429000

338000

371000

2893000

2722000

409000

469000

1527000

214000

429000

72000

5115000

3692000

99000

160000

388000

319000

290000

357000

2000

1500000

237000

2516000

838000

1304000

146000

3820000

984000

190597000

190571000

4129000

8363000

7964000

-193536000

-191698000

1295000

2708000

5115000

3692000

0.001

2500000

280898

0.001

15000000

6188198

6184698

5926137

5775171

399916

1000

33000

11000

1000

22000

1202000

1144000

855000

1103000

2057000

2247000

-2056000

-2225000

-12000

-13000

-2068000

-2238000

-2068000

-2238000

5591000

4073000

-0.37

-0.55

31000

-2068000

-2207000

281000

5775000

190571000

-4129000

7964000

-191698000

2708000

230000

146000

321000

78000

5000

26000

-2068000

281000

5926000

190597000

-4129000

8363000

-193536000

1295000

7000

4097000

190570000

-4128000

1745000

-184164000

-31000

3992000

31000

44000

5000

14000

3000

7000

1000

9000

-2238000

4095000

190565000

-4129000

1793000

-186402000

1827000

104000

36000

141000

75000

-31000

17000

-1000

-61000

-7000

-53000

127000

-1830000

-2247000

3345000

250000

3595000

1000

1500000

7000

321000

1821000

6000

-9000

1354000

1588000

552000

1579000

1906000

1608000

<a name="bm__1__General_Information"></a><a name="bm__1__General_Information"></a>(1) General Information Description of the Company – Astrotech Corporation (Nasdaq: ASTC) (“Astrotech,” “the Company,” “we,” “us,” or “our”), a Delaware corporation organized in 1984, is a science and technology development and commercialization company that launches, manages, and builds scalable companies based on innovative technology in order to maximize shareholder value.   Basis of Presentation – The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the year ending June 30, 2020. These financial statements should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2019.   Our Business Units   Astrotech Technology, Inc.   There are a number of different market opportunities for the mass spectrometry technology that was originally developed by 1st Detect Corporation (“1st Detect”). Astrotech Technology, Inc. (“ATI”) was formed to own and license the intellectual property, which includes 37 patents granted with five additional patents in process, for different fields of use. ATI currently licenses the intellectual property to 1st Detect for use in the security and detection market and to Agriculture Technology Corporation (“AG-TECH”) for use in the agriculture market.   1st Detect Corporation   1st Detect, a licensee of ATI, has developed the TRACER 1000™, the world’s first certified mass spectrometer (“MS”)-based explosives trace detector (“ETD”), designed to replace the explosives and narcotics trace detectors used at airports, secured facilities, and borders worldwide.   Agriculture Technology Corporation   AG-TECH, a licensee of ATI, has developed the AG-LAB-1000™ series of mass spectrometers for use in the agriculture market. The technology can detect trace levels of pesticides in agricultural products in real-time and it has garnered initial interest from the hemp and cannabis market. It can characterize and quantify the cannabinoids (including tetrahydrocannabinol (“THC”), cannabidiol (“CBD”), and many other constituents) and terpenes (aromatic oils) present in the plant or plant derivatives.   Astral Images Corporation   Astral Images Corporation (“Astral”) developed advanced film restoration and enhancement software. Although we believe Astral has developed valuable technology fortified by patents and trade secrets, the potential market has not yet evolved. Due to funding constraints, the Company’s primary focus remains on the pursuit of opportunities for its platform mass spectrometry technology. Consequently, headcount and expenditures at Astral have been minimized and new development is exclusively focused on strategic initiatives that would facilitate the realization of Astral’s value.   Accounting Pronouncements – In February 2016, the Financial Standards Accounting Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-02: Leases (“Topic 842” or “ASU 2016-02”) and ASU 2018-10: Codification Improvements to Topic 842, Leases (“ASU 2018-10”) which provide an additional (and optional) transition method whereby the new lease standard is applied at the adoption date and recognized as an adjustment to retained earnings. This ASU requires lessees to recognize a right-of-use (“ROU”) asset and lease liability on the balance sheet for all leases, with the exception of short-term leases. The asset will be based on the liability, subject to adjustment, such as for initial direct costs. For statement of operations purposes, leases are still required to be classified as either operating or financing. Operating leases will result in straight-line expense while financing leases will result in a front-loaded expense pattern.   On July 1, 2019, the Company adopted Topic 842 using the modified retrospective approach and the impact of the adoption of Topic 842 resulted in the recognition of an ROU asset and lease obligation on the Company’s condensed consolidated balance sheets of approximately $1.6 million and an adjustment to retained earnings of $230 thousand. This application of the modified retrospective method will result in a balance sheet presentation that will not be comparable to the prior period in the first year of adoption. Results for reporting periods after July 1, 2019 are presented under Topic 842, while prior periods have not been adjusted. The Company elected the package of practical expedients permitted under the transition guidance within the new standard which, among other things, allowed the Company to carry forward the historical lease classifications. See Note 3 Leases for more information.   In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. For assets held at amortized cost basis, ASU 2016-13 eliminates the probable initial recognition threshold in current generally accepted accounting standards, and, instead, requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For available-for-sale debt securities, credit losses should be measured in a manner similar to current generally accepted accounting standards; however, ASU 2016-13 will require that credit losses be presented as an allowance rather than as a write-down. ASU 2016-13 affects entities holding financial assets and net investment in leases that are not accounted for at fair value through net income. This amendment affects loans, debt securities, trade receivables, net investments in leases, off balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of this standard and does not believe it will have a material impact on its financial statements.   <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2018, the FASB issued ASU 2018-13, “Fair Value measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”). ASU 2018-13 removes certain disclosure requirements, including the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. ASU 2018-13 also adds disclosure requirements, including changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements, and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. ASU 2018-13 is effective for annual reporting periods, and interim periods therein, beginning after December 15, 2019, with early adoption permitted. The amendments on changes in unrealized gains and losses, and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The Company does not expect the adoption of this guidance to have a material impact on its financial statements.

<a name="bm__2__Going_Concern"></a>(<a name="bm__2__Going_Concern"></a>2) Going Concern Financial Condition The Company’s consolidated financial statements for the three months ended September 30, 2019 have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of September 30, 2019, the Company has working capital of $0.4 million. The Company reported a net loss of $7.5 million for the fiscal year 2019 and a net loss of $2.1 million for the three months ended September 30, 2019, along with net cash used in operating activities of $8.5 million for the fiscal year 2019 and net cash used in operating activities of $1.8 million for the three months ended September 30, 2019. This raises substantial doubt about the Company’s ability to continue as a going concern. Management’s Plans to Continue as a Going Concern The Company remains resolute in identifying the optimal solution to its liquidity issue. The Company is currently evaluating several potential sources for additional liquidity. These include, but are not limited to, selling the Company or a portion thereof, debt financing, equity financing, merging, or engaging in a strategic partnership. On July 3, 2018, management filed Form S-3 to raise funds through the capital markets. On October 9, 2018, the Company raised $3.0 million in a private placement of equity securities to the Company’s Chairman of the Board and Chief Executive Officer, Thomas B. Pickens III, and a long-term accredited investor in the Company. On April 17, 2019, the Company raised $2.0 million in a private placement of equity securities to Mr. Pickens, and a long-term accredited investor in the Company. On September 5, 2019, the Company entered into a private placement transaction with Mr. Pickens for the issuance and sale of a secured promissory note to Mr. Pickens with a principal amount of $1.5 million. As of September 30, 2019, the Company has received net proceeds of approximately $1.4 million through the sale of shares of common stock through an “at the market offering” program (the “ATM Offering”). The Company is currently evaluating potential offerings of any combination of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock or debt securities, or any combination of the foregoing, either individually or as units comprised of one or more of the other securities. However, additional funding may not be available when needed or on terms acceptable to us.  If we are unable to generate funding within a reasonable timeframe, we may have to delay, reduce or terminate our research and development programs, limit strategic opportunities, or curtail our business activities. Astrotech’s consolidated financial statements as of September 30, 2019 do not include any adjustments that might result from the outcome of this uncertainty.

<a name="bm__3__Investments"></a>(3) Leases<a name="bm__3__Investments"></a>   <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of July 1, 2019, the Company adopted Topic 842, using the modified retrospective method of adoption. Astrotech elected to use the transition option that allows the Company to initially apply the new lease standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the year of adoption. Comparable periods continue to be presented under the guidance of the previous standard, Accounting Standards Codification (“ASC”) Topic 840. Topic 842 requires lessees to recognize a lease liability and ROU asset on the balance sheet for operating leases. The adoption of Topic 842 resulted in an adjustment to retained earnings of $230 thousand.   <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has two existing facility leases and several small equipment leases. Astrotech leases office space consisting of 5,219 square feet in Austin, Texas and houses executive management, finance and accounting, and marketing and communications. The lease began in November 2016 and expires in December 2023 with a provision to renew and extend the lease for the entire premises for one renewal term of five years. Astrotech must, in writing, advise the landlord of its intention to renew the lease at least eight months before the expiration of its current lease in order to renew the lease. In May 2013, 1st Detect completed build-out of a 16,540 square foot leased research and development and production facility in Webster, Texas. This facility is equipped with state-of-the-art laboratories, a clean room, a production shop, and offices for staff. The term of the lease is 62 months and includes options to extend for two additional five-year periods. In February 2015, 1st Detect exercised its right of first refusal on the adjoining space of 9,138 square feet. The original lease began in May 2013 and was to expire in June 2018; these dates were amended in October 2014 with the amended lease beginning February 1, 2015, and expiring April 30, 2020, with provisions to renew and extend the lease for the entire premises, but not less than the entire premises, for two renewal terms of five years each. On June 1, 2018, the Company entered into its third amendment of the original lease removing 8,118 square feet from its leased space, leaving leased premises with a total square footage of 17,560. The Company included the assumption that 1st Detect will occupy comparable space to its current location with a new five-year lease in its calculations for adopting Topic 842. The Company has not entered into any financing leases.   <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate used at adoption was 11%. Significant judgement is required when determining the Company’s incremental borrowing rate. Lease expense for lease payments is recognized on a straight-line basis over the lease term.   <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The condensed consolidated balance sheet classification of lease assets and liabilities are as follows:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> (In thousands)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%; border-bottom:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Assets</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.26%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets, beginning balance</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,608</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:75.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current period amortization</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(81</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:75.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating lease right-of-use asset</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,527</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table>   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> (In thousands)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%; border-bottom:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.26%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities - current</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">237</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:75.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities - non-current</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,304</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:75.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease liabilities</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,541</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>  </div>   Future minimum lease payments as of September 30, 2019 under non-cancellable operating leases are as follows:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> (In thousands)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%; border-bottom:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended June 30,</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.26%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">292</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">414</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">425</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">434</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">258</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:75.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">188</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease payments</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,011</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:75.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: imputed interest</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">470</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liability</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,541</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:75.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: operating lease liabilities - current</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">237</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:75.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities - non-current</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,304</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>   Cash payments for operating leases for the three months ended September 30, 2019 totaled $96 thousand. The weighted-average remaining lease term for operating leases is 5.1 years.

<a name="bm__5__Noncontrolling_Interest"></a>(4<a name="bm__5__Noncontrolling_Interest"></a>) Stockholders’ Equity   A prospectus relating to the ATM Offering was filed with the SEC on November 9, 2018. Since its filing, as of September 30, 2019, the Company has sold 360,668 shares of common stock pursuant to an At the Market Issuance Sales Agreement with B. Riley FBR, under which B. Riley FBR acts as sales agent. In connection with the sale of these shares of common stock, the Company has received net proceeds of $1.4 million. The weighted-average sale price per share was $3.80.   <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s stockholders’ equity as of September 30, 2019 was less than $2.5 million, which is less than the requirement under Nasdaq Listing Rule 5550(b)(1) for continued listing on The Nasdaq Capital Market. As a result, though no assurance can be given, the Company anticipates that Nasdaq will provide notice of this development and require the Company to take steps in order to avoid the delisting of its common stock.

<a name="bm__6__Net_Income__Loss__per_Share"></a>(5<a name="bm__6__Net_Income__Loss__per_Share"></a>) Net Loss per Share   Basic net loss per share is computed on the basis of the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed based on the weighted average number of common shares outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method and the if-converted method. Potentially dilutive common shares include outstanding stock options and share-based awards.   The following table reconciles the numerators and denominators used in the computations of both basic and diluted net loss per share:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.32%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%; border-bottom:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands, except per share data)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Numerator:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,068</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,238</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Denominator:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator for basic and diluted net loss per share — weighted average common stock outstanding</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,591</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,073</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per common share:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.37</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.55</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> </table></div>   All unvested restricted stock awards for the three months ended September 30, 2019 are not included in diluted net loss per share, as the impact to net loss per share would be anti-dilutive. Options to purchase 324,153 shares of common stock at exercise prices ranging from $2.83 to $8.35 per share outstanding as of September 30, 2019 were not included in diluted net loss per share, as the impact to net loss per share would be anti-dilutive.

<a name="bm__9__Other_Comprehensive_Loss"></a>(8) Term Note Payable<a name="bm__9__Other_Comprehensive_Loss"></a> – Related Party   <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 5, 2019, the Company entered into a private placement transaction with Thomas B. Pickens III, the Chief Executive Officer and Chairman of the Board of Directors of the Company for the issuance and sale of a secured promissory note (“the Note”) to Mr. Pickens with a principal amount of $1.5 million. Interest on the Note shall accrue at 11% per annum. The principal amount and accrued interest on the Note shall become due and payable on September 5, 2020 (the “Maturity Date”). The Company may prepay the principal amount and all accrued interest on the Note at any time prior to the Maturity Date. In connection with the issuance of the Note, the Company, along with 1st Detect Corporation and Astrotech Technologies, Inc. (the “Subsidiaries”), entered into a security agreement, dated as of September 5, 2019, with Mr. Pickens (the “Security Agreement”), pursuant to which the Company and the Subsidiaries granted to Mr. Pickens a security interest in all of the Company’s and the Subsidiaries’ Collateral, as such term is defined in the Security Agreement. In addition, the Subsidiaries jointly and severally agreed to guarantee and act as surety for the Company’s obligation to repay the Note pursuant to a subsidiary guarantee (the “Subsidiary Guarantee”).

<a name="bm__10__Credit_Risk_and_Concentrations"></a>(9) Business Risk a<a name="bm__10__Credit_Risk_and_Concentrations"></a>nd Credit Risk Concentration Involving Cash   The Company maintains funds in bank accounts that may exceed the limit insured by the Federal Deposit Insurance Corporation of $250 thousand per depositor. The risk of loss attributable to these uninsured balances is mitigated by depositing funds in what we believe to be high credit quality financial institutions. The Company has not experienced any losses in such accounts.

<a name="bm__11__Common_Stock_Incentive__Stock_Pu"></a>(10<a name="bm__11__Common_Stock_Incentive__Stock_Pu"></a>) Common Stock Compensation   Stock Option Activity Summary   The Company’s stock option activity for the three months ended September 30, 2019, is as follows:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.18%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.86%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.86%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at June 30, 2019</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">324</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.71</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.18%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Canceled or expired</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.18%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at September 30, 2019</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">324</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.71</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>   The aggregate intrinsic value of options exercisable at September 30, 2019, was $0, as the fair value of the Company’s common stock is less than the exercise prices of these options. The remaining stock-based compensation expense of $106 thousand related to stock options will be recognized over a weighted-average period of 0.61 years.   The table below details the Company’s stock options outstanding as of September 30, 2019:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.9%; border-bottom:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Range of exercise prices</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted- <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Life (years)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted- <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercisable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted- <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.9%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$2.83 – 3.55</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70,500</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.73</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.39</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70,500</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.39</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$5.30 – 5.85</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">123,653</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.61</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.48</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79,575</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.48</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.9%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$6.00 – 8.35</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">130,000</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.15</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.19</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86,000</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.59</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr style="height:13.15pt;"> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.9%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$2.83 – 8.35</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">324,153</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.56</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.71</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">236,075</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.26</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>   Compensation costs recognized related to stock option awards were $44 thousand and $41 thousand for the three months ended September 30, 2019, and 2018.   Restricted Stock   The Company’s restricted stock activity for the three months ended September 30, 2019, is as follows:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.18%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.86%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.86%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant-Date <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at June 30, 2019</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">208</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">4.06</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.47</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.88</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.18%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Canceled or expired</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.18%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at September 30, 2019</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">209</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3.81</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>   Stock compensation expenses related to restricted stock were $60 thousand and ($5) thousand for the three months ended September 30, 2019, and 2018. The remaining stock-based compensation expense of $496 thousand related to restricted stock awards granted will be recognized over a weighted-average period of 2.17 years.

<a name="bm__12__Income_Taxes"></a>(11<a name="bm__12__Income_Taxes"></a>) Income Taxes The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. Valuation allowances are established, when necessary, to reduce deferred tax assets to amounts that are more likely than not to be realized. As of September 30, 2019, the Company established a valuation allowance against all of its net deferred tax assets. For the three months ended September 30, 2019 and 2018, the Company incurred pre-tax losses in the amount of $2.1 million and $2.2 million, respectively. The total effective tax rate was approximately 0% for the each of the three months ended September 30, 2019 and 2018. For the each of the three months ended September 30, 2019 and 2018, the Company’s effective tax rate differed from the federal statutory rate of 21%, primarily due to the valuation allowance placed against its net deferred tax assets.  The Tax Cuts and Jobs Act was enacted on December 22, 2017 and provides for a refundable credit of any AMT previously paid. The AMT credit receivable by the Company of $857 thousand for AMT previously paid will be refunded subsequent to the filing of returns for fiscal years ending June 30, 2019, June 30, 2020, June 30, 2021 and June 30, 2022. Credit amounts calculated for such years are $429 thousand, $214 thousand, $107 thousand, and $107 thousand, respectively. FASB ASC 740, “Income Taxes” addresses the accounting for uncertainty in income tax recognized in an entity’s financial statements and prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken or expected to be taken on a tax return. The Company had no unrecognized tax benefit for the three months ended September 30, 2019 or 2018. Loss carryovers are generally subject to modification by tax authorities until three years after they have been utilized; as such, the Company is subject to examination for the fiscal years ended 2000 through present for federal purposes and fiscal years ended 2006 through present for state purposes. The reason for this extended examination period is due to the utilization of the loss carryovers generated by the sale of our Astrotech Space Operations business unit in fiscal year 2015.

<a name="bm__13__Commitments_and_Contingencies"></a>(12<a name="bm__13__Commitments_and_Contingencies"></a>) Commitments and Contingencies   The Company is subject to various lawsuits and other claims in the normal course of business. In addition, from time to time, the Company receives communications from government or regulatory agencies concerning investigations or allegations of noncompliance with laws or regulations in jurisdictions in which the Company operates.   The Company establishes reserves for the estimated losses on specific contingent liabilities, for regulatory and legal actions where the Company deems a loss to be probable and the amount of the loss can be reasonably estimated. In other instances, the Company is not able to make a reasonable estimate of liability because of the uncertainties related to the outcome or the amount or range of potential loss.   Litigation, Investigations, and Audits – We are not party to, nor are our properties the subject of, any material pending legal proceedings.

Our Business Units   Astrotech Technology, Inc.   There are a number of different market opportunities for the mass spectrometry technology that was originally developed by 1st Detect Corporation (“1st Detect”). Astrotech Technology, Inc. (“ATI”) was formed to own and license the intellectual property, which includes 37 patents granted with five additional patents in process, for different fields of use. ATI currently licenses the intellectual property to 1st Detect for use in the security and detection market and to Agriculture Technology Corporation (“AG-TECH”) for use in the agriculture market.   1st Detect Corporation   1st Detect, a licensee of ATI, has developed the TRACER 1000™, the world’s first certified mass spectrometer (“MS”)-based explosives trace detector (“ETD”), designed to replace the explosives and narcotics trace detectors used at airports, secured facilities, and borders worldwide.   Agriculture Technology Corporation   AG-TECH, a licensee of ATI, has developed the AG-LAB-1000™ series of mass spectrometers for use in the agriculture market. The technology can detect trace levels of pesticides in agricultural products in real-time and it has garnered initial interest from the hemp and cannabis market. It can characterize and quantify the cannabinoids (including tetrahydrocannabinol (“THC”), cannabidiol (“CBD”), and many other constituents) and terpenes (aromatic oils) present in the plant or plant derivatives.   Astral Images Corporation   Astral Images Corporation (“Astral”) developed advanced film restoration and enhancement software. Although we believe Astral has developed valuable technology fortified by patents and trade secrets, the potential market has not yet evolved. Due to funding constraints, the Company’s primary focus remains on the pursuit of opportunities for its platform mass spectrometry technology. Consequently, headcount and expenditures at Astral have been minimized and new development is exclusively focused on strategic initiatives that would facilitate the realization of Astral’s value.

Accounting Pronouncements – In February 2016, the Financial Standards Accounting Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-02: Leases (“Topic 842” or “ASU 2016-02”) and ASU 2018-10: Codification Improvements to Topic 842, Leases (“ASU 2018-10”) which provide an additional (and optional) transition method whereby the new lease standard is applied at the adoption date and recognized as an adjustment to retained earnings. This ASU requires lessees to recognize a right-of-use (“ROU”) asset and lease liability on the balance sheet for all leases, with the exception of short-term leases. The asset will be based on the liability, subject to adjustment, such as for initial direct costs. For statement of operations purposes, leases are still required to be classified as either operating or financing. Operating leases will result in straight-line expense while financing leases will result in a front-loaded expense pattern.   On July 1, 2019, the Company adopted Topic 842 using the modified retrospective approach and the impact of the adoption of Topic 842 resulted in the recognition of an ROU asset and lease obligation on the Company’s condensed consolidated balance sheets of approximately $1.6 million and an adjustment to retained earnings of $230 thousand. This application of the modified retrospective method will result in a balance sheet presentation that will not be comparable to the prior period in the first year of adoption. Results for reporting periods after July 1, 2019 are presented under Topic 842, while prior periods have not been adjusted. The Company elected the package of practical expedients permitted under the transition guidance within the new standard which, among other things, allowed the Company to carry forward the historical lease classifications. See Note 3 Leases for more information.   In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. For assets held at amortized cost basis, ASU 2016-13 eliminates the probable initial recognition threshold in current generally accepted accounting standards, and, instead, requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For available-for-sale debt securities, credit losses should be measured in a manner similar to current generally accepted accounting standards; however, ASU 2016-13 will require that credit losses be presented as an allowance rather than as a write-down. ASU 2016-13 affects entities holding financial assets and net investment in leases that are not accounted for at fair value through net income. This amendment affects loans, debt securities, trade receivables, net investments in leases, off balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of this standard and does not believe it will have a material impact on its financial statements.   <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2018, the FASB issued ASU 2018-13, “Fair Value measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”). ASU 2018-13 removes certain disclosure requirements, including the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. ASU 2018-13 also adds disclosure requirements, including changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements, and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. ASU 2018-13 is effective for annual reporting periods, and interim periods therein, beginning after December 15, 2019, with early adoption permitted. The amendments on changes in unrealized gains and losses, and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The Company does not expect the adoption of this guidance to have a material impact on its financial statements.

FASB ASC 740, “Income Taxes” addresses the accounting for uncertainty in income tax recognized in an entity’s financial statements and prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken or expected to be taken on a tax return. The Company had no unrecognized tax benefit for the three months ended September 30, 2019 or 2018. Loss carryovers are generally subject to modification by tax authorities until three years after they have been utilized; as such, the Company is subject to examination for the fiscal years ended 2000 through present for federal purposes and fiscal years ended 2006 through present for state purposes. The reason for this extended examination period is due to the utilization of the loss carryovers generated by the sale of our Astrotech Space Operations business unit in fiscal year 2015.

<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The condensed consolidated balance sheet classification of lease assets and liabilities are as follows:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> (In thousands)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%; border-bottom:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Assets</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.26%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets, beginning balance</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,608</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:75.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current period amortization</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(81</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:75.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating lease right-of-use asset</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,527</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> (In thousands)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%; border-bottom:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.26%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities - current</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">237</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:75.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities - non-current</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,304</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:75.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease liabilities</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,541</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

Future minimum lease payments as of September 30, 2019 under non-cancellable operating leases are as follows:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> (In thousands)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%; border-bottom:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended June 30,</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.26%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">292</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">414</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">425</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">434</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">258</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:75.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">188</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease payments</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,011</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:75.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: imputed interest</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">470</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:75.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liability</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,541</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:75.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: operating lease liabilities - current</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">237</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:75.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities - non-current</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,304</td> <td valign="middle" bgcolor="#CFF0FF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

The following table reconciles the numerators and denominators used in the computations of both basic and diluted net loss per share:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.32%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%; border-bottom:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands, except per share data)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Numerator:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,068</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,238</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Denominator:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator for basic and diluted net loss per share — weighted average common stock outstanding</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,591</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,073</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per common share:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.37</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.55</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> </table></div>

The Company’s stock option activity for the three months ended September 30, 2019, is as follows:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.18%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.86%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.86%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at June 30, 2019</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">324</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.71</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.18%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Canceled or expired</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.18%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at September 30, 2019</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">324</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.71</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

The table below details the Company’s stock options outstanding as of September 30, 2019:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.9%; border-bottom:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Range of exercise prices</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted- <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Life (years)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted- <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercisable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted- <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.9%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$2.83 – 3.55</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70,500</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.73</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.39</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70,500</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.39</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$5.30 – 5.85</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">123,653</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.61</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.48</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79,575</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.48</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.9%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$6.00 – 8.35</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">130,000</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.15</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.19</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86,000</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.59</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr style="height:13.15pt;"> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.9%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$2.83 – 8.35</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">324,153</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.56</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.71</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">236,075</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.26</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

37 5

1600000

230000

400000

-7500000

-8500000

3000000

2000000

1400000

1500000

5219

2023-12-31

true

P5Y

P8M

P62M

16540

true

9138

P5Y

2 2

2018-06-30

2020-04-30

8118 17560

0.11

1608000

81000

1541000

292000

414000

425000

434000

258000

188000

2011000

470000

96000

P5Y1M6D

360668

1400000

3.80

2500000

324153

2.83

8.35

0.11

2020-09-05

250000

324000

5.71

106000

P7M9D

2.83

5.30

6.00

3.55

5.85

8.35

70500

123653

130000

324153

P2Y8M23D

P7Y7M9D

P5Y1M24D

P5Y6M21D

3.39

5.48

7.19

5.71

70500

79575

86000

236075

3.39

5.48

6.59

5.26

44000

41000

208000

5000

4000

209000

4.06

2.47

8.88

3.81

60000

-5000

496000

P2Y2M1D

0.00

0.21

857000

429000 214000 107000 107000

EX-101.SCH 8 astc-20190930.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - Condensed Consolidated Balance Sheets link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - Condensed Consolidated Statement of Changes in Stockholders' Equity link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - Condensed Consolidated Statement of Changes in Stockholders' Equity (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100060 - Statement - Condensed Consolidated Statements of Cash Flows link:calculationLink link:presentationLink link:definitionLink 100070 - Disclosure - General Information link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Going Concern link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Leases link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Stockholders' Equity link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Net Loss per Share link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Revenue Recognition link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Fair Value Measurement link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Term Note Payable - Related Party link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Business Risk and Credit Risk Concentration Involving Cash link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Common Stock Compensation link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Segment Information link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - General Information (Policies) link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Leases (Tables) link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Net Loss per Share (Tables) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Common Stock Compensation (Tables) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - General Information - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Going Concern (Details) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Leases - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Leases - Schedule of Condensed Consolidated Balance Sheet Classification of Lease Assets and Liabilities (Details) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Leases - Schedule of Future Minimum Lease Payments (Details) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Leases - Schedule of Future Minimum Lease Payments (Details)2 link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Stockholders' Equity - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - Net Loss per Share - Basic and Diluted Computation (Details) link:calculationLink link:presentationLink link:definitionLink 100320 - Disclosure - Net Loss per Share - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 100330 - Disclosure - Term Note Payable - Related Party - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100340 - Disclosure - Business Risk and Credit Risk Concentration Involving Cash - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 100350 - Disclosure - Common Stock Compensation - Stock Option Activity (Details) link:calculationLink link:presentationLink link:definitionLink 100360 - Disclosure - Common Stock Compensation - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 100370 - Disclosure - Common Stock Compensation - Stock Options by Exercise Price (Details) link:calculationLink link:presentationLink link:definitionLink 100380 - Disclosure - Common Stock Compensation - Restricted Stock (Details) link:calculationLink link:presentationLink link:definitionLink 100390 - Disclosure - Income Taxes (Details) link:calculationLink link:presentationLink link:definitionLink 100400 - Disclosure - Segment Information - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 9 astc-20190930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 10 astc-20190930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 11 astc-20190930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Trading Symbol Trading Symbol Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Entity Current Reporting Status Entity Current Reporting Status Entity Shell Company Entity Shell Company Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Entity Interactive Data Current Entity Interactive Data Current Title of 12(b) Security Security12b Title Security Exchange Name Security Exchange Name Entity Incorporation, State or Country Code Entity Incorporation State Country Code Document Quarterly Report Document Quarterly Report Document Transition Report Document Transition Report Statement Of Financial Position [Abstract] Statement [Table] Statement [Table] Class of Stock Statement Class Of Stock [Axis] Class of Stock Class Of Stock [Domain] Convertible Preferred Stock Convertible Preferred Stock [Member] Statement [Line Items] Statement [Line Items] Assets Assets [Abstract] Current assets Assets Current [Abstract] Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Accounts receivable Accounts Receivable Net Current Inventory: Inventory Net [Abstract] Raw materials Inventory Raw Materials Net Of Reserves Work-in-process Inventory Work In Process Income tax receivable Income Taxes Receivable Prepaid expenses and other current assets Prepaid Expense And Other Assets Current Total current assets Assets Current Property and equipment, net Property Plant And Equipment Net Operating leases, right-of-use assets Operating Lease Right Of Use Asset Long-term tax receivable Income Taxes Receivable Noncurrent Other assets Other Assets Noncurrent Total assets Assets Liabilities and stockholders’ equity Liabilities And Stockholders Equity [Abstract] Current liabilities Liabilities Current [Abstract] Accounts payable Accounts Payable Current Payroll related accruals Employee Related Liabilities Current Accrued expenses and other liabilities Accrued Liabilities And Other Liabilities Income tax payable Accrued Income Taxes Current Term note payable - related party Notes Payable Related Parties Classified Current Operating lease liabilities - current Operating Lease Liability Current Total current liabilities Liabilities Current Operating lease liabilities, non - current Operating Lease Liability Noncurrent Other liabilities Other Liabilities Noncurrent Total liabilities Liabilities Commitments and contingencies (Note 12) Commitments And Contingencies Stockholders’ equity Stockholders Equity [Abstract] Convertible preferred stock, $0.001 par value, 2,500,000 shares authorized; 280,898 shares of Series C and 280,898 shares of Series D issued and outstanding at September 30, 2019 and June 30, 2019, respectively Preferred Stock Value Common stock, $0.001 par value, 15,000,000 shares authorized; 6,188,198 and 6,184,698 shares issued at September 30, 2019 and June 30, 2019, respectively; 5,926,137 and 5,775,171 shares outstanding at September 30, 2019 and June 30, 2019, respectively Common Stock Value Treasury stock, 399,916 shares at cost at September 30, 2019 and June 30, 2019, respectively Treasury Stock Value Additional paid-in capital Additional Paid In Capital Accumulated deficit Retained Earnings Accumulated Deficit Total stockholders’ equity Stockholders Equity Total liabilities and stockholders’ equity Liabilities And Stockholders Equity Series C Convertible Preferred Stock Series C Preferred Stock [Member] Series D Convertible Preferred Stock Series D Preferred Stock [Member] Preferred stock, par value (in dollars per share) Preferred Stock No Par Value Preferred stock, shares authorized (in shares) Preferred Stock Shares Authorized Preferred stock, shares issued (in shares) Preferred Stock Shares Issued Preferred stock, shares outstanding (in shares) Preferred Stock Shares Outstanding Common stock, par value (in dollars per share) Common Stock No Par Value Common stock, shares authorized (in shares) Common Stock Shares Authorized Common stock, shares issued (in shares) Common Stock Shares Issued Common stock, shares outstanding (in shares) Common Stock Shares Outstanding Treasury stock, shares at cost (in shares) Treasury Stock Shares Income Statement [Abstract] Revenue Revenues Cost of revenue Cost Of Revenue Gross profit Gross Profit Operating expenses: Operating Expenses [Abstract] Selling, general and administrative Selling General And Administrative Expense Research and development Research And Development Expense Total operating expenses Operating Expenses Loss from operations Operating Income Loss Interest and other expense, net Nonoperating Income Expense Loss from operations before income taxes Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Income tax benefit Income Tax Expense Benefit Net loss Net Income Loss Weighted average common shares outstanding: Earnings Per Share Basic And Diluted Other Disclosures [Abstract] Basic and diluted Weighted Average Number Of Share Outstanding Basic And Diluted Basic and diluted net loss per common share: Earnings Per Share Basic And Diluted [Abstract] Net loss Earnings Per Share Basic And Diluted Other comprehensive loss, net of tax: Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract] Net loss Available-for-sale securities: Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent [Abstract] Reclassification adjustment for realized loss Other Comprehensive Income Loss Reclassification Adjustment From A O C I For Writedown Of Securities Net Of Tax Total comprehensive loss Comprehensive Income Net Of Tax Statement Of Stockholders Equity [Abstract] Equity Components Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common Stock Common Stock [Member] Treasury Stock Amount Treasury Stock [Member] Additional Paid-In Capital Additional Paid In Capital [Member] Accumulated Deficit Retained Earnings [Member] Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Income [Member] Series C convertible preferred stock. Preferred Stock Class C Series C Convertible Preferred Stock [Member] Series D convertible preferred stock. Preferred Stock Class D Series D Convertible Preferred Stock [Member] Adjustments for New Accounting Pronouncements Adjustments For New Accounting Pronouncements [Axis] Type of Adoption Type Of Adoption [Member] ASU 2016-02 Accounting Standards Update201602 [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase Decrease In Stockholders Equity Roll Forward Balance, beginning of period Stockholders Equity Including Portion Attributable To Noncontrolling Interest Balance (in shares) Shares Outstanding Net change in available-for-sale debt and marketable equity securities Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax Adjustment to opening retained earnings related to adoption of ASC Topic 842 Cumulative Effect On Retained Earnings Net Of Tax1 Issuance of shares Stock Issued During Period Value New Issues Issuance of shares (in shares) Stock Issued During Period Shares New Issues Stock-based compensation Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options Cancellation of restricted stock Stock Issued During Period Value Restricted Stock Award Forfeitures Cancellation of restricted stock (in shares) Stock Issued During Period Shares Restricted Stock Award Forfeited Forfeiture of stock options Stock Issued During Period Value Share Based Compensation Forfeited Exercise of stock options Stock Issued During Period Value Stock Options Exercised Exercise of stock options (in shares) Stock Issued During Period Shares Share Based Compensation Share repurchases Treasury Stock Value Acquired Cost Method Share repurchases (in shares) Treasury Stock Shares Acquired Restricted stock issuance Stock Issued During Period Value Restricted Stock Award Gross Restricted stock issuance (in shares) Stock Issued During Period Shares Restricted Stock Award Gross Net loss Profit Loss Balance, end of period Balance (in shares) Stock offering issuance costs Payments Of Stock Issuance Costs Statement Of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided By Used In Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Stock-based compensation Share Based Compensation Depreciation and amortization Depreciation Depletion And Amortization Net loss on sale of available-for-sale investments Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments Changes in assets and liabilities: Increase Decrease In Operating Capital [Abstract] Accounts receivable Increase Decrease In Accounts Receivable Inventory Increase Decrease In Inventories Accounts payable Increase Decrease In Accounts Payable Other assets and liabilities Increase Decrease In Other Operating Capital Net Net cash used in operating activities Net Cash Provided By Used In Operating Activities Cash flows from investing activities: Net Cash Provided By Used In Investing Activities [Abstract] Proceeds from sale of available-for-sale investments Proceeds From Sale Of Available For Sale Securities Proceeds from maturities of securities Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities Net cash provided by investing activities Net Cash Provided By Used In Investing Activities Cash flows from financing activities: Net Cash Provided By Used In Financing Activities [Abstract] Payments for purchase of treasury stock Payments For Repurchase Of Equity Proceeds from term note payable - related party Proceeds From Related Party Debt Proceeds from exercise of stock options Proceeds From Stock Options Exercised Proceeds from issuance of stock, net of offering issuance costs Proceeds From Issuance Of Common Stock Net cash provided by financing activities Net Cash Provided By Used In Financing Activities Net change in cash and cash equivalents Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Cash and cash equivalents at beginning of period Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations Cash and cash equivalents at end of period Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Cash paid for interest Interest Paid Net Income taxes paid Income Taxes Paid Impact to retained earnings from adoption of ASC Topic 842 Operating right-of-use assets and associated liabilities Right Of Use Asset Obtained In Exchange For Operating Lease Liability Organization Consolidation And Presentation Of Financial Statements [Abstract] General Information Business Description And Basis Of Presentation [Text Block] Going Concern Substantial Doubt About Going Concern [Text Block] Leases [Abstract] Leases Lessee Operating Leases [Text Block] Equity [Abstract] Stockholders' Equity Stockholders Equity Note Disclosure [Text Block] Earnings Per Share [Abstract] Net Loss per Share Earnings Per Share [Text Block] Revenue Recognition [Abstract] Revenue Recognition Revenue From Contract With Customer [Text Block] Fair Value Disclosures [Abstract] Fair Value Measurement Fair Value Disclosures [Text Block] Debt Disclosure [Abstract] Term Note Payable - Related Party Debt Disclosure [Text Block] Risks And Uncertainties [Abstract] Business Risk and Credit Risk Concentration Involving Cash Concentration Risk Disclosure [Text Block] Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Common Stock Compensation Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Segment Reporting [Abstract] Segment Information Segment Reporting Disclosure [Text Block] Basis of Presentation EX-101.PRE 12 astc-20190930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 13 R28.htm IDEA: XBRL DOCUMENT

Leases - Schedule of Condensed Consolidated Balance Sheet Classification of Lease Assets and Liabilities (Details) $ in Thousands	3 Months Ended
	Sep. 30, 2019 USD ($)
Leases [Abstract]
Operating lease right-of-use assets, beginning balance	$ 1,608
Current period amortization	(81)
Total operating lease right-of-use asset	1,527
Operating lease liabilities - current	237
Operating lease liabilities, non - current	1,304
Total lease liabilities	$ 1,541

XML 14 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statement of Changes in Stockholders' Equity (Parenthetical) $ in Thousands	3 Months Ended
	Sep. 30, 2019 USD ($)
Statement Of Stockholders Equity [Abstract]
Stock offering issuance costs	$ 7

XML 15 R20.htm IDEA: XBRL DOCUMENT

Segment Information

3 Months Ended

Sep. 30, 2019

Segment Reporting [Abstract]

Segment Information

(13) Segment Information

XML 16 R24.htm IDEA: XBRL DOCUMENT

Common Stock Compensation (Tables)

3 Months Ended

Sep. 30, 2019

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Schedule of stock option activity

The Company’s stock option activity for the three months ended September 30, 2019, is as follows:

	Shares (in thousands)		Weighted Average Exercise Price
Outstanding at June 30, 2019		324	$	5.71
Granted		—		—
Exercised		—		—
Canceled or expired		—		—
Outstanding at September 30, 2019		324	$	5.71

Schedule of stock options by exercise price

The table below details the Company’s stock options outstanding as of September 30, 2019:

Range of exercise prices	Number Outstanding		Options Outstanding Weighted- Average Remaining Contractual Life (years)		Weighted- Average Exercise Price		Number Exercisable		Options Exercisable Weighted- Average Exercise Price
$2.83 – 3.55		70,500		2.73	$	3.39		70,500	$	3.39
$5.30 – 5.85		123,653		7.61		5.48		79,575		5.48
$6.00 – 8.35		130,000		5.15		7.19		86,000		6.59
$2.83 – 8.35		324,153		5.56	$	5.71		236,075	$	5.26

Schedule of restricted stock activity

The Company’s restricted stock activity for the three months ended September 30, 2019, is as follows:

	Shares (in thousands)			Weighted Average Grant-Date Fair Value
Outstanding at June 30, 2019		208		$	4.06
Granted		5			2.47
Vested		(4	)		8.88
Canceled or expired		—			—
Outstanding at September 30, 2019		209		$	3.81

XML 17 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2019	Jun. 30, 2019
Current assets
Cash and cash equivalents	$ 1,579	$ 1,588
Accounts receivable	3	3
Inventory:
Raw materials	121	150
Work-in-process	209	181
Income tax receivable	643	429
Prepaid expenses and other current assets	338	371
Total current assets	2,893	2,722
Property and equipment, net	409	469
Operating leases, right-of-use assets	1,527
Long-term tax receivable	214	429
Other assets	72	72
Total assets	5,115	3,692
Current liabilities
Accounts payable	99	160
Payroll related accruals	388	319
Accrued expenses and other liabilities	290	357
Income tax payable	2	2
Term note payable - related party	1,500
Operating lease liabilities - current	237
Total current liabilities	2,516	838
Operating lease liabilities, non - current	1,304
Other liabilities		146
Total liabilities	3,820	984
Commitments and contingencies (Note 12)
Stockholders’ equity
Common stock, $0.001 par value, 15,000,000 shares authorized; 6,188,198 and 6,184,698 shares issued at September 30, 2019 and June 30, 2019, respectively; 5,926,137 and 5,775,171 shares outstanding at September 30, 2019 and June 30, 2019, respectively	190,597	190,571
Treasury stock, 399,916 shares at cost at September 30, 2019 and June 30, 2019, respectively	(4,129)	(4,129)
Additional paid-in capital	8,363	7,964
Accumulated deficit	(193,536)	(191,698)
Total stockholders’ equity	1,295	2,708
Total liabilities and stockholders’ equity	5,115	3,692
Convertible Preferred Stock
Stockholders’ equity
Convertible preferred stock, $0.001 par value, 2,500,000 shares authorized; 280,898 shares of Series C and 280,898 shares of Series D issued and outstanding at September 30, 2019 and June 30, 2019, respectively

XML 18 R12.htm IDEA: XBRL DOCUMENT

Net Loss per Share

3 Months Ended

Sep. 30, 2019

Earnings Per Share [Abstract]

Net Loss per Share

(5) Net Loss per Share

The following table reconciles the numerators and denominators used in the computations of both basic and diluted net loss per share:

	Three Months Ended September 30,
(In thousands, except per share data)	2019			2018
Numerator:
Net loss	$	(2,068	)	$	(2,238	)
Denominator:
Denominator for basic and diluted net loss per share — weighted average common stock outstanding		5,591			4,073
Basic and diluted net loss per common share:
Net loss	$	(0.37	)	$	(0.55	)

XML 19 R16.htm IDEA: XBRL DOCUMENT

Business Risk and Credit Risk Concentration Involving Cash

3 Months Ended

Sep. 30, 2019

Risks And Uncertainties [Abstract]

Business Risk and Credit Risk Concentration Involving Cash

(9) Business Risk and Credit Risk Concentration Involving Cash

XML 20 R35.htm IDEA: XBRL DOCUMENT

Common Stock Compensation - Stock Option Activity (Details) shares in Thousands	3 Months Ended
	Sep. 30, 2019 $ / shares shares
Shares
Outstanding, beginning of period \| shares	324
Granted \| shares	0
Exercised \| shares	0
Canceled or expired \| shares	0
Outstanding, end of period \| shares	324
Weighted Average Exercise Price
Outstanding, beginning of period \| $ / shares	$ 5.71
Granted \| $ / shares	0
Exercised \| $ / shares	0
Canceled or expired \| $ / shares	0
Outstanding, end of period \| $ / shares	$ 5.71

XML 21 R31.htm IDEA: XBRL DOCUMENT

Net Loss per Share - Basic and Diluted Computation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		12 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Jun. 30, 2019
Numerator:
Net loss	$ (2,068)	$ (2,238)	$ (7,500)
Denominator:
Denominator for basic and diluted net loss per share — weighted average common stock outstanding	5,591	4,073
Basic and diluted net loss per common share:
Net loss	$ (0.37)	$ (0.55)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 22 R39.htm IDEA: XBRL DOCUMENT

Income Taxes (Details) - USD ($)	3 Months Ended		12 Months Ended
Income Taxes (Details) - USD ($)	Sep. 30, 2019	Sep. 30, 2018	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2018
Income Tax [Line Items]
Loss before income taxes	$ (2,068,000)	$ (2,238,000)
Effective tax rate for continuing operations	0.00%	0.00%
Federal statutory effective tax rate	21.00%	21.00%
Alternative minimum tax credit receivable							$ 857,000
Alternative minimum tax credit to be refunded						$ 429,000
Unrecognized tax benefits	$ 0	$ 0
Forecast
Income Tax [Line Items]
Tax Cuts And Jobs Act Of 2017 Alternative minimum tax credit refundable			$ 107,000	$ 107,000	$ 214,000

XML 23 R13.htm IDEA: XBRL DOCUMENT

Revenue Recognition

3 Months Ended

Sep. 30, 2019

Revenue Recognition [Abstract]

Revenue Recognition

(6) Revenue Recognition

Astrotech recognizes revenue employing the generally accepted revenue recognition methodologies described under the provisions of ASC Topic 606 “Revenue from Contracts with Customers” (“Topic 606”), which was adopted by the Company in fiscal year 2019. The methodology used is based on contract type and how products and services are provided. The guidelines of Topic 606 establish a five-step process to govern the recognition and reporting of revenue from contracts with customers. The five steps are: (i) identify the contract with a customer, (ii) identify the performance obligations within the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations within the contract, and (v) recognize revenue when or as the performance obligations are satisfied.

XML 24 R17.htm IDEA: XBRL DOCUMENT

Common Stock Compensation

3 Months Ended

Sep. 30, 2019

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Common Stock Compensation

(10) Common Stock Compensation

Stock Option Activity Summary

The Company’s stock option activity for the three months ended September 30, 2019, is as follows:

	Shares (in thousands)		Weighted Average Exercise Price
Outstanding at June 30, 2019		324	$	5.71
Granted		—		—
Exercised		—		—
Canceled or expired		—		—
Outstanding at September 30, 2019		324	$	5.71

The table below details the Company’s stock options outstanding as of September 30, 2019:

Range of exercise prices	Number Outstanding		Options Outstanding Weighted- Average Remaining Contractual Life (years)		Weighted- Average Exercise Price		Number Exercisable		Options Exercisable Weighted- Average Exercise Price
$2.83 – 3.55		70,500		2.73	$	3.39		70,500	$	3.39
$5.30 – 5.85		123,653		7.61		5.48		79,575		5.48
$6.00 – 8.35		130,000		5.15		7.19		86,000		6.59
$2.83 – 8.35		324,153		5.56	$	5.71		236,075	$	5.26

Compensation costs recognized related to stock option awards were $44 thousand and $41 thousand for the three months ended September 30, 2019, and 2018.

Restricted Stock

The Company’s restricted stock activity for the three months ended September 30, 2019, is as follows:

	Shares (in thousands)			Weighted Average Grant-Date Fair Value
Outstanding at June 30, 2019		208		$	4.06
Granted		5			2.47
Vested		(4	)		8.88
Canceled or expired		—			—
Outstanding at September 30, 2019		209		$	3.81

XML 25 R38.htm IDEA: XBRL DOCUMENT

Common Stock Compensation - Restricted Stock (Details) - Restricted Stock shares in Thousands	3 Months Ended
	Sep. 30, 2019 $ / shares shares
Shares
Outstanding, beginning of period \| shares	208
Granted \| shares	5
Vested \| shares	(4)
Canceled or expired \| shares	0
Outstanding, end of period \| shares	209
Weighted Average Grant-Date Fair Value
Outstanding, beginning of period \| $ / shares	$ 4.06
Granted \| $ / shares	2.47
Vested \| $ / shares	8.88
Canceled or expired \| $ / shares	0
Outstanding, end of period \| $ / shares	$ 3.81

XML 26 R34.htm IDEA: XBRL DOCUMENT

Business Risk and Credit Risk Concentration Involving Cash - Narrative (Details) $ in Thousands	Sep. 30, 2019 USD ($)
Risks And Uncertainties [Abstract]
Federal Deposit Insurance Corporation amount per depositor	$ 250

XML 27 R30.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		11 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Jun. 30, 2019
Class Of Stock [Line Items]
Net proceeds from sale of common stock	$ 321	$ 0	$ 1,400
Stockholders’ equity	1,295		1,295	$ 2,708
Maximum
Class Of Stock [Line Items]
Stockholders’ equity	$ 2,500		$ 2,500
Common Stock
Class Of Stock [Line Items]
Shares agreed to sell upon agreement	146,000
Common Stock \| Market Issuance Sales Agreement
Class Of Stock [Line Items]
Shares agreed to sell upon agreement			360,668
Net proceeds from sale of common stock			$ 1,400
Average sale price per share			$ 3.80

EXCEL 29 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 30 R40.htm IDEA: XBRL DOCUMENT v3.19.3

Segment Information - Narrative (Details) - segment
3 Months Ended 12 Months Ended

Sep. 30, 2019

Jun. 30, 2019

Segment Reporting [Abstract]

Number of reportable business unit 1 2

X

- Definition
Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.
+ References
No definition available.
+ Details

Name: us-gaap_NumberOfReportableSegments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.19.3

General Information (Policies)
3 Months Ended

Sep. 30, 2019

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Basis of Presentation
Basis of Presentation – The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the year ending June 30, 2020. These financial statements should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2019.

Our Business Units
Our Business Units

Astrotech Technology, Inc.

There are a number of different market opportunities for the mass spectrometry technology that was originally developed by 1^st Detect Corporation (“1^st Detect”). Astrotech Technology, Inc. (“ATI”) was formed to own and license the intellectual property, which includes 37 patents granted with five additional patents in process, for different fields of use. ATI currently licenses the intellectual property to 1^st Detect for use in the security and detection market and to Agriculture Technology Corporation (“AG-TECH”) for use in the agriculture market.

1^st Detect Corporation

1^st Detect, a licensee of ATI, has developed the TRACER 1000™, the world’s first certified mass spectrometer (“MS”)-based explosives trace detector (“ETD”), designed to replace the explosives and narcotics trace detectors used at airports, secured facilities, and borders worldwide.

Agriculture Technology Corporation

AG-TECH, a licensee of ATI, has developed the AG-LAB-1000™ series of mass spectrometers for use in the agriculture market. The technology can detect trace levels of pesticides in agricultural products in real-time and it has garnered initial interest from the hemp and cannabis market. It can characterize and quantify the cannabinoids (including tetrahydrocannabinol (“THC”), cannabidiol (“CBD”), and many other constituents) and terpenes (aromatic oils) present in the plant or plant derivatives.

Astral Images Corporation

Astral Images Corporation (“Astral”) developed advanced film restoration and enhancement software. Although we believe Astral has developed valuable technology fortified by patents and trade secrets, the potential market has not yet evolved. Due to funding constraints, the Company’s primary focus remains on the pursuit of opportunities for its platform mass spectrometry technology. Consequently, headcount and expenditures at Astral have been minimized and new development is exclusively focused on strategic initiatives that would facilitate the realization of Astral’s value.

Accounting Pronouncements
Accounting Pronouncements – In February 2016, the Financial Standards Accounting Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-02: Leases (“Topic 842” or “ASU 2016-02”) and ASU 2018-10: Codification Improvements to Topic 842, Leases (“ASU 2018-10”) which provide an additional (and optional) transition method whereby the new lease standard is applied at the adoption date and recognized as an adjustment to retained earnings. This ASU requires lessees to recognize a right-of-use (“ROU”) asset and lease liability on the balance sheet for all leases, with the exception of short-term leases. The asset will be based on the liability, subject to adjustment, such as for initial direct costs. For statement of operations purposes, leases are still required to be classified as either operating or financing. Operating leases will result in straight-line expense while financing leases will result in a front-loaded expense pattern.

On July 1, 2019, the Company adopted Topic 842 using the modified retrospective approach and the impact of the adoption of Topic 842 resulted in the recognition of an ROU asset and lease obligation on the Company’s condensed consolidated balance sheets of approximately $1.6 million and an adjustment to retained earnings of $230 thousand. This application of the modified retrospective method will result in a balance sheet presentation that will not be comparable to the prior period in the first year of adoption. Results for reporting periods after July 1, 2019 are presented under Topic 842, while prior periods have not been adjusted. The Company elected the package of practical expedients permitted under the transition guidance within the new standard which, among other things, allowed the Company to carry forward the historical lease classifications. See Note 3 Leases for more information.

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. For assets held at amortized cost basis, ASU 2016-13 eliminates the probable initial recognition threshold in current generally accepted accounting standards, and, instead, requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For available-for-sale debt securities, credit losses should be measured in a manner similar to current generally accepted accounting standards; however, ASU 2016-13 will require that credit losses be presented as an allowance rather than as a write-down. ASU 2016-13 affects entities holding financial assets and net investment in leases that are not accounted for at fair value through net income. This amendment affects loans, debt securities, trade receivables, net investments in leases, off balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of this standard and does not believe it will have a material impact on its financial statements.

In August 2018, the FASB issued ASU 2018-13, “Fair Value measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”). ASU 2018-13 removes certain disclosure requirements, including the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. ASU 2018-13 also adds disclosure requirements, including changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements, and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. ASU 2018-13 is effective for annual reporting periods, and interim periods therein, beginning after December 15, 2019, with early adoption permitted. The amendments on changes in unrealized gains and losses, and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The Company does not expect the adoption of this guidance to have a material impact on its financial statements.

Income Taxes
FASB ASC 740, “Income Taxes” addresses the accounting for uncertainty in income tax recognized in an entity’s financial statements and prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken or expected to be taken on a tax return. The Company had no unrecognized tax benefit for the three months ended September 30, 2019 or 2018.

Loss carryovers are generally subject to modification by tax authorities until three years after they have been utilized; as such, the Company is subject to examination for the fiscal years ended 2000 through present for federal purposes and fiscal years ended 2006 through present for state purposes. The reason for this extended examination period is due to the utilization of the loss carryovers generated by the sale of our Astrotech Space Operations business unit in fiscal year 2015.

X

- Definition
Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BasisOfAccountingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 740
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=116821951&loc=d3e32247-109318

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=116821951&loc=d3e32280-109318

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 05
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327
+ Details

Name: us-gaap_IncomeTaxPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for segment reporting.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790
+ Details

Name: us-gaap_SegmentReportingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 32 R7.htm IDEA: XBRL DOCUMENT v3.19.3

Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 11 Months Ended 12 Months Ended

Sep. 30, 2019

Sep. 30, 2018

Sep. 30, 2019

Jun. 30, 2019

Cash flows from operating activities:

Net loss $ (2,068) $ (2,238)

Adjustments to reconcile net loss to net cash used in operating activities:

Stock-based compensation 104 36

Depreciation and amortization 141 75

Net loss on sale of available-for-sale investments 0 31

Changes in assets and liabilities:

Accounts receivable 0 (17)

Inventory 1 0

Accounts payable (61) (7)

Other assets and liabilities 53 (127)

Net cash used in operating activities (1,830) (2,247) $ (8,500)

Cash flows from investing activities:

Proceeds from sale of available-for-sale investments 0 3,345

Proceeds from maturities of securities 0 250

Net cash provided by investing activities 0 3,595

Cash flows from financing activities:

Payments for purchase of treasury stock 0 (1)

Proceeds from term note payable - related party 1,500 0

Proceeds from exercise of stock options 0 7

Proceeds from issuance of stock, net of offering issuance costs 321 0 $ 1,400

Net cash provided by financing activities 1,821 6

Net change in cash and cash equivalents (9) 1,354

Cash and cash equivalents at beginning of period 1,588 552 552

Cash and cash equivalents at end of period 1,579 1,906 $ 1,579 $ 1,588

Supplemental disclosures of cash flow information:

Cash paid for interest 0 0

Income taxes paid 0 0

Operating right-of-use assets and associated liabilities 1,608 0

ASU 2016-02

Supplemental disclosures of cash flow information:

Impact to retained earnings from adoption of ASC Topic 842 $ 230 $ 0

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
This item represents the difference between the gross realized gains and losses realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities.
+ References
No definition available.
+ Details

Name: us-gaap_AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585
+ Details

Name: us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585
+ Details

Name: us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the cumulative effect on retained earnings net of related income tax effect.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794
+ Details

Name: us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585
+ Details

Name: us-gaap_IncomeTaxesPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 17
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585
+ Details

Name: us-gaap_InterestPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow to reacquire common and preferred stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsForRepurchaseOfEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from the additional capital contribution to the entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=118954083&loc=d3e26853-111562

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3151-108585

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585
+ Details

Name: us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromRelatedPartyDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=118954083&loc=d3e26853-111562

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585
+ Details

Name: us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from exercise of option under share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=SL79508275-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase in right-of-use asset obtained in exchange for operating lease liability.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 55
-Paragraph 53
-URI http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (g)(2)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980
+ Details

Name: us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of noncash expense for share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 33 R3.htm IDEA: XBRL DOCUMENT v3.19.3

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares

Sep. 30, 2019

Jun. 30, 2019

Common stock, par value (in dollars per share) $ 0.001 $ 0.001

Common stock, shares authorized (in shares) 15,000,000 15,000,000

Common stock, shares issued (in shares) 6,188,198 6,184,698

Common stock, shares outstanding (in shares) 5,926,137 5,775,171

Treasury stock, shares at cost (in shares) 399,916 399,916

Convertible Preferred Stock

Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001

Preferred stock, shares authorized (in shares) 2,500,000 2,500,000

Series C Convertible Preferred Stock

Preferred stock, shares issued (in shares) 280,898 280,898

Preferred stock, shares outstanding (in shares) 280,898 280,898

Series D Convertible Preferred Stock

Preferred stock, shares issued (in shares) 280,898 280,898

Preferred stock, shares outstanding (in shares) 280,898 280,898

X

- Definition
Face amount per share of no-par value common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockNoParValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockNoParValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29,30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655
+ Details

Name: us-gaap_TreasuryStockShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 34 R25.htm IDEA: XBRL DOCUMENT v3.19.3

General Information - Additional Information (Details)
$ in Thousands

Sep. 30, 2019

USD ($)

Patent

Jul. 01, 2019

USD ($)

General Information [Line Items]

Number of patents granted | Patent 37

Number of additional patents in process | Patent 5

ROU asset $ 1,527 $ 1,608

Lease obligation $ 1,541

ASU 2016-02

General Information [Line Items]

ROU asset 1,600

Lease obligation 1,600

Cumulative impact of change in accounting policy $ 230

X

- Definition
General information.
+ References
No definition available.
+ Details

Name: astc_GeneralInformationLineItems

Namespace Prefix: astc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of additional patents in process.
+ References
No definition available.
+ Details

Name: astc_NumberOfAdditionalPatentsInProcess

Namespace Prefix: astc_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of patents granted.
+ References
No definition available.
+ Details

Name: astc_NumberOfPatentsGranted

Namespace Prefix: astc_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.
+ References
No definition available.
+ Details

Name: us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's right to use underlying asset under operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseRightOfUseAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 35 R29.htm IDEA: XBRL DOCUMENT v3.19.3

Leases - Schedule of Future Minimum Lease Payments (Details)
$ in Thousands

Sep. 30, 2019

USD ($)

Leases [Abstract]

2020 $ 292

2021 414

2022 425

2023 434

2024 258

Thereafter 188

Total lease payments 2,011

Less: imputed interest 470

Total lease liabilities 1,541

Operating lease liabilities - current 237

Operating lease liabilities, non - current $ 1,304

X

- References
No definition available.
+ Details

Name: us-gaap_LeasesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 36 R36.htm IDEA: XBRL DOCUMENT v3.19.3

Common Stock Compensation - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended

Sep. 30, 2019

Sep. 30, 2018

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Aggregate intrinsic value of options exercisable $ 0

Remaining stock-based compensation expense $ 106

Weighted average recognition period on remaining share-based compensation expense 7 months 9 days

Employee Stock Option

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Compensation expense recognized $ 44 $ 41

Restricted Stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Weighted average recognition period on remaining share-based compensation expense 2 years 2 months 1 day

Compensation expense recognized $ 60 $ (5)

Remaining stock-based compensation expense $ 496

X

- Definition
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of cost to be recognized for option under share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 37 R32.htm IDEA: XBRL DOCUMENT v3.19.3

Net Loss per Share - Narrative (Details)
3 Months Ended

Sep. 30, 2019

$ / shares

shares

Earnings Per Share [Abstract]

Options to purchase (in shares) | shares 324,153

Exercise price lower range (in dollars per share) $ 2.83

Exercise price upper range (in dollars per share) $ 8.35

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

XML 38 R19.htm IDEA: XBRL DOCUMENT v3.19.3

Commitments and Contingencies
3 Months Ended

Sep. 30, 2019

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies
(12) Commitments and Contingencies

The Company is subject to various lawsuits and other claims in the normal course of business. In addition, from time to time, the Company receives communications from government or regulatory agencies concerning investigations or allegations of noncompliance with laws or regulations in jurisdictions in which the Company operates.

The Company establishes reserves for the estimated losses on specific contingent liabilities, for regulatory and legal actions where the Company deems a loss to be probable and the amount of the loss can be reasonably estimated. In other instances, the Company is not able to make a reasonable estimate of liability because of the uncertainties related to the outcome or the amount or range of potential loss.

Litigation, Investigations, and Audits – We are not party to, nor are our properties the subject of, any material pending legal proceedings.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-URI http://asc.fasb.org/topic&trid=2127136

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-URI http://asc.fasb.org/topic&trid=2144648
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 79 282 1 false 25 0 false 8 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 100040 - Statement - Condensed Consolidated Statement of Changes in Stockholders' Equity Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/StatementCondensedConsolidatedStatementOfChangesInStockholdersEquity Condensed Consolidated Statement of Changes in Stockholders' Equity Statements 5 false false R6.htm 100050 - Statement - Condensed Consolidated Statement of Changes in Stockholders' Equity (Parenthetical) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/StatementCondensedConsolidatedStatementOfChangesInStockholdersEquityParenthetical Condensed Consolidated Statement of Changes in Stockholders' Equity (Parenthetical) Statements 6 false false R7.htm 100060 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 100070 - Disclosure - General Information Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureGeneralInformation General Information Notes 8 false false R9.htm 100080 - Disclosure - Going Concern Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureGoingConcern Going Concern Notes 9 false false R10.htm 100090 - Disclosure - Leases Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureLeases Leases Notes 10 false false R11.htm 100100 - Disclosure - Stockholders' Equity Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureStockholdersEquity Stockholders' Equity Notes 11 false false R12.htm 100110 - Disclosure - Net Loss per Share Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureNetLossPerShare Net Loss per Share Notes 12 false false R13.htm 100120 - Disclosure - Revenue Recognition Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureRevenueRecognition Revenue Recognition Notes 13 false false R14.htm 100130 - Disclosure - Fair Value Measurement Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureFairValueMeasurement Fair Value Measurement Notes 14 false false R15.htm 100140 - Disclosure - Term Note Payable - Related Party Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureTermNotePayableRelatedParty Term Note Payable - Related Party Notes 15 false false R16.htm 100150 - Disclosure - Business Risk and Credit Risk Concentration Involving Cash Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureBusinessRiskAndCreditRiskConcentrationInvolvingCash Business Risk and Credit Risk Concentration Involving Cash Notes 16 false false R17.htm 100160 - Disclosure - Common Stock Compensation Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureCommonStockCompensation Common Stock Compensation Notes 17 false false R18.htm 100170 - Disclosure - Income Taxes Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 18 false false R19.htm 100180 - Disclosure - Commitments and Contingencies Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 19 false false R20.htm 100190 - Disclosure - Segment Information Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureSegmentInformation Segment Information Notes 20 false false R21.htm 100200 - Disclosure - General Information (Policies) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureGeneralInformationPolicies General Information (Policies) Policies 21 false false R22.htm 100210 - Disclosure - Leases (Tables) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureLeasesTables Leases (Tables) Tables http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureLeases 22 false false R23.htm 100220 - Disclosure - Net Loss per Share (Tables) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureNetLossPerShareTables Net Loss per Share (Tables) Tables http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureNetLossPerShare 23 false false R24.htm 100230 - Disclosure - Common Stock Compensation (Tables) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureCommonStockCompensationTables Common Stock Compensation (Tables) Tables http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureCommonStockCompensation 24 false false R25.htm 100240 - Disclosure - General Information - Additional Information (Details) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureGeneralInformationAdditionalInformationDetails General Information - Additional Information (Details) Details 25 false false R26.htm 100250 - Disclosure - Going Concern (Details) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureGoingConcernDetails Going Concern (Details) Details http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureGoingConcern 26 false false R27.htm 100260 - Disclosure - Leases - Additional Information (Details) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails Leases - Additional Information (Details) Details 27 false false R28.htm 100270 - Disclosure - Leases - Schedule of Condensed Consolidated Balance Sheet Classification of Lease Assets and Liabilities (Details) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureLeasesScheduleOfCondensedConsolidatedBalanceSheetClassificationOfLeaseAssetsAndLiabilitiesDetails Leases - Schedule of Condensed Consolidated Balance Sheet Classification of Lease Assets and Liabilities (Details) Details 28 false false R29.htm 100280 - Disclosure - Leases - Schedule of Future Minimum Lease Payments (Details) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsDetails Leases - Schedule of Future Minimum Lease Payments (Details) Details 29 false false R30.htm 100300 - Disclosure - Stockholders' Equity - Narrative (Details) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureStockholdersEquityNarrativeDetails Stockholders' Equity - Narrative (Details) Details 30 false false R31.htm 100310 - Disclosure - Net Loss per Share - Basic and Diluted Computation (Details) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureNetLossPerShareBasicAndDilutedComputationDetails Net Loss per Share - Basic and Diluted Computation (Details) Details 31 false false R32.htm 100320 - Disclosure - Net Loss per Share - Narrative (Details) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureNetLossPerShareNarrativeDetails Net Loss per Share - Narrative (Details) Details 32 false false R33.htm 100330 - Disclosure - Term Note Payable - Related Party - Additional Information (Details) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureTermNotePayableRelatedPartyAdditionalInformationDetails Term Note Payable - Related Party - Additional Information (Details) Details 33 false false R34.htm 100340 - Disclosure - Business Risk and Credit Risk Concentration Involving Cash - Narrative (Details) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureBusinessRiskAndCreditRiskConcentrationInvolvingCashNarrativeDetails Business Risk and Credit Risk Concentration Involving Cash - Narrative (Details) Details http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureBusinessRiskAndCreditRiskConcentrationInvolvingCash 34 false false R35.htm 100350 - Disclosure - Common Stock Compensation - Stock Option Activity (Details) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureCommonStockCompensationStockOptionActivityDetails Common Stock Compensation - Stock Option Activity (Details) Details 35 false false R36.htm 100360 - Disclosure - Common Stock Compensation - Narrative (Details) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureCommonStockCompensationNarrativeDetails Common Stock Compensation - Narrative (Details) Details 36 false false R37.htm 100370 - Disclosure - Common Stock Compensation - Stock Options by Exercise Price (Details) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureCommonStockCompensationStockOptionsByExercisePriceDetails Common Stock Compensation - Stock Options by Exercise Price (Details) Details 37 false false R38.htm 100380 - Disclosure - Common Stock Compensation - Restricted Stock (Details) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureCommonStockCompensationRestrictedStockDetails Common Stock Compensation - Restricted Stock (Details) Details 38 false false R39.htm 100390 - Disclosure - Income Taxes (Details) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureIncomeTaxesDetails Income Taxes (Details) Details http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureIncomeTaxes 39 false false R40.htm 100400 - Disclosure - Segment Information - Narrative (Details) Sheet http://www.astrotechcorp.com/20190930/taxonomy/role/DisclosureSegmentInformationNarrativeDetails Segment Information - Narrative (Details) Details 40 false false All Reports Book All Reports astc-20190930.xml astc-20190930.xsd astc-20190930_cal.xml astc-20190930_def.xml astc-20190930_lab.xml astc-20190930_pre.xml http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true XML 40 R11.htm IDEA: XBRL DOCUMENT v3.19.3

Stockholders' Equity
3 Months Ended

Sep. 30, 2019

Equity [Abstract]

Stockholders' Equity
(4) Stockholders’ Equity

A prospectus relating to the ATM Offering was filed with the SEC on November 9, 2018. Since its filing, as of September 30, 2019, the Company has sold 360,668 shares of common stock pursuant to an At the Market Issuance Sales Agreement with B. Riley FBR, under which B. Riley FBR acts as sales agent. In connection with the sale of these shares of common stock, the Company has received net proceeds of $1.4 million. The weighted-average sale price per share was $3.80.

The Company’s stockholders’ equity as of September 30, 2019 was less than $2.5 million, which is less than the requirement under Nasdaq Listing Rule 5550(b)(1) for continued listing on The Nasdaq Capital Market. As a result, though no assurance can be given, the Company anticipates that Nasdaq will provide notice of this development and require the Company to take steps in order to avoid the delisting of its common stock.

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762
+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

ZIP 41 0001564590-19-043442-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-19-043442-xbrl.zip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end XML 42 R15.htm IDEA: XBRL DOCUMENT v3.19.3

Term Note Payable - Related Party
3 Months Ended

Sep. 30, 2019

Debt Disclosure [Abstract]

Term Note Payable - Related Party
(8) Term Note Payable – Related Party

On September 5, 2019, the Company entered into a private placement transaction with Thomas B. Pickens III, the Chief Executive Officer and Chairman of the Board of Directors of the Company for the issuance and sale of a secured promissory note (“the Note”) to Mr. Pickens with a principal amount of $1.5 million. Interest on the Note shall accrue at 11% per annum. The principal amount and accrued interest on the Note shall become due and payable on September 5, 2020 (the “Maturity Date”). The Company may prepay the principal amount and all accrued interest on the Note at any time prior to the Maturity Date. In connection with the issuance of the Note, the Company, along with 1^st Detect Corporation and Astrotech Technologies, Inc. (the “Subsidiaries”), entered into a security agreement, dated as of September 5, 2019, with Mr. Pickens (the “Security Agreement”), pursuant to which the Company and the Subsidiaries granted to Mr. Pickens a security interest in all of the Company’s and the Subsidiaries’ Collateral, as such term is defined in the Security Agreement. In addition, the Subsidiaries jointly and severally agreed to guarantee and act as surety for the Company’s obligation to repay the Note pursuant to a subsidiary guarantee (the “Subsidiary Guarantee”).

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564
+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 44 R5.htm IDEA: XBRL DOCUMENT v3.19.3

Condensed Consolidated Statement of Changes in Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands

Total

Preferred Stock Class C

Preferred Stock Class D

Common Stock

Treasury Stock Amount

Additional Paid-In Capital

Accumulated Deficit

Accumulated Other Comprehensive Loss

Balance, beginning of period at Jun. 30, 2018 $ 3,992 $ 190,570 $ (4,128) $ 1,745 $ (184,164) $ (31)

Balance (in shares) at Jun. 30, 2018 4,097

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net change in available-for-sale debt and marketable equity securities 31 $ 31

Adjustment to opening retained earnings related to adoption of ASC Topic 842 | ASU 2016-02 0

Stock-based compensation 44 44

Cancellation of restricted stock (14) $ (14)

Cancellation of restricted stock (in shares) (5)

Forfeiture of stock options (3) (3)

Exercise of stock options 7 7

Exercise of stock options (in shares) 3

Share repurchases (1) (1)

Restricted stock issuance 9 $ 9

Net loss (2,238) (2,238)

Balance, end of period at Sep. 30, 2018 1,827 $ 190,565 (4,129) 1,793 (186,402)

Balance (in shares) at Sep. 30, 2018 4,095

Balance, beginning of period at Jun. 30, 2019 2,708 $ 190,571 (4,129) 7,964 (191,698)

Balance (in shares) at Jun. 30, 2019 281 281 5,775

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Adjustment to opening retained earnings related to adoption of ASC Topic 842 | ASU 2016-02 230 230

Issuance of shares 321 321

Issuance of shares (in shares) 146

Stock-based compensation 78 78

Restricted stock issuance 26 $ 26

Restricted stock issuance (in shares) 5

Net loss (2,068) (2,068)

Balance, end of period at Sep. 30, 2019 $ 1,295 $ 190,597 $ (4,129) $ 8,363 $ (193,536)

Balance (in shares) at Sep. 30, 2019 281 281 5,926

X

- Definition
Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement.
+ References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of the cumulative effect on retained earnings net of related income tax effect.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794
+ Details

Name: us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInStockholdersEquityRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before tax, after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares issued which are neither cancelled nor held in the treasury.
+ References
No definition available.
+ Details

Name: us-gaap_SharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares related to Restricted Stock Award forfeited during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of stock related to Restricted Stock Awards forfeited during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate value of stock related to Restricted Stock Awards issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph c(1)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Value of stock issued as a result of the exercise of stock options.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_TreasuryStockValueAcquiredCostMethod

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 45 R23.htm IDEA: XBRL DOCUMENT v3.19.3

Net Loss per Share (Tables)
3 Months Ended

Sep. 30, 2019

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted
The following table reconciles the numerators and denominators used in the computations of both basic and diluted net loss per share:

Three Months Ended

September 30,

(In thousands, except per share data)

2019

2018

Numerator:

Net loss

$

(2,068

)

$

(2,238

)

Denominator:

Denominator for basic and diluted net loss per share — weighted average common stock outstanding

5,591

4,073

Basic and diluted net loss per common share:

Net loss

$

(0.37

)

$

(0.55

)

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 46 R27.htm IDEA: XBRL DOCUMENT v3.19.3

Leases - Additional Information (Details)
$ in Thousands
1 Months Ended 3 Months Ended

Nov. 30, 2016

ft²

renewal_term

Oct. 31, 2014

renewal_term

May 31, 2013

ft²

renewal_term

Sep. 30, 2019

USD ($)

Jul. 01, 2019

USD ($)

Jun. 01, 2018

ft²

Feb. 28, 2015

ft²

Leases [Line Items]

Incremental borrowing rate 11.00%

Cash payments | $ $ 96

Weighted-average remaining lease term for operating leases 5 years 1 month 6 days

1st Detect

Leases [Line Items]

Lease, expiration date Apr. 30, 2020

Lessee, Operating Lease, Existence of Option to Extend [true false] true

Number of renewal terms | renewal_term 2

Renewal term 5 years

Leased premises, right of first refusal exercised 9,138

Austin, Texas

Leases [Line Items]

Leased premises 5,219

Lease, expiration date Dec. 31, 2023

Lessee, Operating Lease, Existence of Option to Extend [true false] true

Number of renewal terms | renewal_term 1

Renewal term 5 years

Period before expiration of lease that renewal contract must be signed 8 months

Webster, Texas

Leases [Line Items]

Original lease area of land removed 8,118

Leased premises remaining area 17,560

Webster, Texas | 1st Detect | Research and Development and Production Facility

Leases [Line Items]

Leased premises 16,540

Lease, expiration date Jun. 30, 2018

Lessee, Operating Lease, Existence of Option to Extend [true false] true

Number of renewal terms | renewal_term 2

Renewal term 5 years

Lease term 62 months

ASU 2016-02

Leases [Line Items]

Cumulative impact of change in accounting policy | $ $ 230

X

- Definition
Area of land right of first refusal exercised.
+ References
No definition available.
+ Details

Name: astc_AreaOfLandRightOfFirstRefusalExercised

Namespace Prefix: astc_

Data Type: num:areaItemType

Balance Type: na

Period Type: instant

X

- Definition
Leases.
+ References
No definition available.
+ Details

Name: astc_LeasesLineItems

Namespace Prefix: astc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Lessee Leasing Arrangements, Operating Leases, Renewal Notification Period
+ References
No definition available.
+ Details

Name: astc_LesseeLeasingArrangementsOperatingLeasesRenewalNotificationPeriod

Namespace Prefix: astc_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents number of renewal terms.
+ References
No definition available.
+ Details

Name: astc_NumberOfRenewalTerms

Namespace Prefix: astc_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Original lease area of land removed.
+ References
No definition available.
+ Details

Name: astc_OriginalLeaseAreaOfLandRemoved

Namespace Prefix: astc_

Data Type: num:areaItemType

Balance Type: na

Period Type: instant

X

- Definition
Remaining area of land.
+ References
No definition available.
+ Details

Name: astc_RemainingAreaOfLand

Namespace Prefix: astc_

Data Type: num:areaItemType

Balance Type: na

Period Type: instant

X

- Definition
Area of land held.
+ References
No definition available.
+ Details

Name: us-gaap_AreaOfLand

Namespace Prefix: us-gaap_

Data Type: num:areaItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.
+ References
No definition available.
+ Details

Name: us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Date which lease or group of leases is set to expire, in CCYY-MM-DD format.
+ References
No definition available.
+ Details

Name: us-gaap_LeaseExpirationDate1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Discount rate used by lessee to determine present value of operating lease payments.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (c)(3)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseDiscountRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicates (true false) whether lessee has option to extend operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend

Namespace Prefix: us-gaap_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseRenewalTerm

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Definition
Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseTermOfContract

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 5
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (g)(1)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980
+ Details

Name: us-gaap_OperatingLeasePayments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 55
-Paragraph 53
-URI http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (g)(3)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980
+ Details

Name: us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=astc_FirstDetectCorporationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_StatementGeographicalAxis=astc_AustinTexasMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_StatementGeographicalAxis=astc_WebsterTexasMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=astc_ResearchAndDevelopmentAndProductionFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 47 R1.htm IDEA: XBRL DOCUMENT v3.19.3

Document and Entity Information - shares
3 Months Ended

Sep. 30, 2019

Nov. 08, 2019

Cover [Abstract]

Entity Registrant Name ASTROTECH Corp

Entity Central Index Key 0001001907

Trading Symbol ASTC

Current Fiscal Year End Date --06-30

Entity Filer Category Non-accelerated Filer

Entity Small Business true

Entity Emerging Growth Company false

Document Type 10-Q

Document Period End Date Sep. 30, 2019

Document Fiscal Year Focus 2020

Document Fiscal Period Focus Q1

Amendment Flag false

Entity Common Stock, Shares Outstanding 5,915,129

Entity Current Reporting Status Yes

Entity Shell Company false

Entity File Number 001-34426

Entity Tax Identification Number 91-1273737

Entity Address, Address Line One 201 West 5th Street

Entity Address, Address Line Two Suite 1275

Entity Address, City or Town Austin

Entity Address, State or Province TX

Entity Address, Postal Zip Code 78701

City Area Code 512

Local Phone Number 485-9530

Entity Interactive Data Current Yes

Title of 12(b) Security Common Stock, $0.001 par value per share

Security Exchange Name NASDAQ

Entity Incorporation, State or Country Code DE

Document Quarterly Report true

Document Transition Report false

X

- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Area code of city
+ References
No definition available.
+ Details

Name: dei_CityAreaCode

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Cover page.
+ References
No definition available.
+ Details

Name: dei_CoverAbstract

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true only for a form used as an quarterly report.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 10-Q
-Number 240
-Section 13
-Subsection a-13
+ Details

Name: dei_DocumentQuarterlyReport

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true only for a form used as a transition report.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Forms 10-K, 10-Q, 20-F
-Number 240
-Section 13
-Subsection a-1-
+ Details

Name: dei_DocumentTransitionReport

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details

Name: dei_EntityAddressAddressLine1

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details

Name: dei_EntityAddressAddressLine2

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Name of the City or Town
+ References
No definition available.
+ Details

Name: dei_EntityAddressCityOrTown

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details

Name: dei_EntityAddressPostalZipCode

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Name of the state or province.
+ References
No definition available.
+ Details

Name: dei_EntityAddressStateOrProvince

Namespace Prefix: dei_

Data Type: dei:stateOrProvinceItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityEmergingGrowthCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details

Name: dei_EntityFileNumber

Namespace Prefix: dei_

Data Type: dei:fileNumberItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details

Name: dei_EntityIncorporationStateCountryCode

Namespace Prefix: dei_

Data Type: dei:edgarStateCountryItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-T
-Number 232
-Section 405
+ Details

Name: dei_EntityInteractiveDataCurrent

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityShellCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicates that the company is a Smaller Reporting Company (SRC).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntitySmallBusiness

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityTaxIdentificationNumber

Namespace Prefix: dei_

Data Type: dei:employerIdItemType

Balance Type: na

Period Type: duration

X

- Definition
Local phone number for entity.
+ References
No definition available.
+ Details

Name: dei_LocalPhoneNumber

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details

Name: dei_Security12bTitle

Namespace Prefix: dei_

Data Type: dei:securityTitleItemType

Balance Type: na

Period Type: duration

X

- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details

Name: dei_SecurityExchangeName

Namespace Prefix: dei_

Data Type: dei:edgarExchangeCodeItemType

Balance Type: na

Period Type: duration

X

- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: dei:tradingSymbolItemType

Balance Type: na

Period Type: duration

XML 48 R9.htm IDEA: XBRL DOCUMENT v3.19.3

Going Concern
3 Months Ended

Sep. 30, 2019

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Going Concern
(2) Going Concern

Financial Condition

The Company’s consolidated financial statements for the three months ended September 30, 2019 have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of September 30, 2019, the Company has working capital of $0.4 million. The Company reported a net loss of $7.5 million for the fiscal year 2019 and a net loss of $2.1 million for the three months ended September 30, 2019, along with net cash used in operating activities of $8.5 million for the fiscal year 2019 and net cash used in operating activities of $1.8 million for the three months ended September 30, 2019. This raises substantial doubt about the Company’s ability to continue as a going concern.

Management’s Plans to Continue as a Going Concern

The Company remains resolute in identifying the optimal solution to its liquidity issue. The Company is currently evaluating several potential sources for additional liquidity. These include, but are not limited to, selling the Company or a portion thereof, debt financing, equity financing, merging, or engaging in a strategic partnership. On July 3, 2018, management filed Form S-3 to raise funds through the capital markets. On October 9, 2018, the Company raised $3.0 million in a private placement of equity securities to the Company’s Chairman of the Board and Chief Executive Officer, Thomas B. Pickens III, and a long-term accredited investor in the Company. On April 17, 2019, the Company raised $2.0 million in a private placement of equity securities to Mr. Pickens, and a long-term accredited investor in the Company. On September 5, 2019, the Company entered into a private placement transaction with Mr. Pickens for the issuance and sale of a secured promissory note to Mr. Pickens with a principal amount of $1.5 million. As of September 30, 2019, the Company has received net proceeds of approximately $1.4 million through the sale of shares of common stock through an “at the market offering” program (the “ATM Offering”). The Company is currently evaluating potential offerings of any combination of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock or debt securities, or any combination of the foregoing, either individually or as units comprised of one or more of the other securities. However, additional funding may not be available when needed or on terms acceptable to us. If we are unable to generate funding within a reasonable timeframe, we may have to delay, reduce or terminate our research and development programs, limit strategic opportunities, or curtail our business activities. Astrotech’s consolidated financial statements as of September 30, 2019 do not include any adjustments that might result from the outcome of this uncertainty.

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 40
-URI http://asc.fasb.org/subtopic&trid=51888271
+ Details

Name: us-gaap_SubstantialDoubtAboutGoingConcernTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 49 R8.htm IDEA: XBRL DOCUMENT v3.19.3

General Information
3 Months Ended

Sep. 30, 2019

Organization Consolidation And Presentation Of Financial Statements [Abstract]

General Information
(1) General Information

Description of the Company – Astrotech Corporation (Nasdaq: ASTC) (“Astrotech,” “the Company,” “we,” “us,” or “our”), a Delaware corporation organized in 1984, is a science and technology development and commercialization company that launches, manages, and builds scalable companies based on innovative technology in order to maximize shareholder value.

Basis of Presentation – The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the year ending June 30, 2020. These financial statements should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2019.

Our Business Units

Astrotech Technology, Inc.

There are a number of different market opportunities for the mass spectrometry technology that was originally developed by 1^st Detect Corporation (“1^st Detect”). Astrotech Technology, Inc. (“ATI”) was formed to own and license the intellectual property, which includes 37 patents granted with five additional patents in process, for different fields of use. ATI currently licenses the intellectual property to 1^st Detect for use in the security and detection market and to Agriculture Technology Corporation (“AG-TECH”) for use in the agriculture market.

1^st Detect Corporation

1^st Detect, a licensee of ATI, has developed the TRACER 1000™, the world’s first certified mass spectrometer (“MS”)-based explosives trace detector (“ETD”), designed to replace the explosives and narcotics trace detectors used at airports, secured facilities, and borders worldwide.

Agriculture Technology Corporation

AG-TECH, a licensee of ATI, has developed the AG-LAB-1000™ series of mass spectrometers for use in the agriculture market. The technology can detect trace levels of pesticides in agricultural products in real-time and it has garnered initial interest from the hemp and cannabis market. It can characterize and quantify the cannabinoids (including tetrahydrocannabinol (“THC”), cannabidiol (“CBD”), and many other constituents) and terpenes (aromatic oils) present in the plant or plant derivatives.

Astral Images Corporation

Astral Images Corporation (“Astral”) developed advanced film restoration and enhancement software. Although we believe Astral has developed valuable technology fortified by patents and trade secrets, the potential market has not yet evolved. Due to funding constraints, the Company’s primary focus remains on the pursuit of opportunities for its platform mass spectrometry technology. Consequently, headcount and expenditures at Astral have been minimized and new development is exclusively focused on strategic initiatives that would facilitate the realization of Astral’s value.

Accounting Pronouncements – In February 2016, the Financial Standards Accounting Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-02: Leases (“Topic 842” or “ASU 2016-02”) and ASU 2018-10: Codification Improvements to Topic 842, Leases (“ASU 2018-10”) which provide an additional (and optional) transition method whereby the new lease standard is applied at the adoption date and recognized as an adjustment to retained earnings. This ASU requires lessees to recognize a right-of-use (“ROU”) asset and lease liability on the balance sheet for all leases, with the exception of short-term leases. The asset will be based on the liability, subject to adjustment, such as for initial direct costs. For statement of operations purposes, leases are still required to be classified as either operating or financing. Operating leases will result in straight-line expense while financing leases will result in a front-loaded expense pattern.

On July 1, 2019, the Company adopted Topic 842 using the modified retrospective approach and the impact of the adoption of Topic 842 resulted in the recognition of an ROU asset and lease obligation on the Company’s condensed consolidated balance sheets of approximately $1.6 million and an adjustment to retained earnings of $230 thousand. This application of the modified retrospective method will result in a balance sheet presentation that will not be comparable to the prior period in the first year of adoption. Results for reporting periods after July 1, 2019 are presented under Topic 842, while prior periods have not been adjusted. The Company elected the package of practical expedients permitted under the transition guidance within the new standard which, among other things, allowed the Company to carry forward the historical lease classifications. See Note 3 Leases for more information.

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. For assets held at amortized cost basis, ASU 2016-13 eliminates the probable initial recognition threshold in current generally accepted accounting standards, and, instead, requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For available-for-sale debt securities, credit losses should be measured in a manner similar to current generally accepted accounting standards; however, ASU 2016-13 will require that credit losses be presented as an allowance rather than as a write-down. ASU 2016-13 affects entities holding financial assets and net investment in leases that are not accounted for at fair value through net income. This amendment affects loans, debt securities, trade receivables, net investments in leases, off balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of this standard and does not believe it will have a material impact on its financial statements.

In August 2018, the FASB issued ASU 2018-13, “Fair Value measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”). ASU 2018-13 removes certain disclosure requirements, including the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. ASU 2018-13 also adds disclosure requirements, including changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements, and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. ASU 2018-13 is effective for annual reporting periods, and interim periods therein, beginning after December 15, 2019, with early adoption permitted. The amendments on changes in unrealized gains and losses, and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The Company does not expect the adoption of this guidance to have a material impact on its financial statements.

X

- Definition
The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-URI http://asc.fasb.org/topic&trid=2122149

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-URI http://asc.fasb.org/topic&trid=2134479
+ Details

Name: us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 50 R22.htm IDEA: XBRL DOCUMENT v3.19.3

Leases (Tables)
3 Months Ended

Sep. 30, 2019

Leases [Abstract]

Schedule of Condensed Consolidated Balance Sheet Classification of Lease Assets and Liabilities

The condensed consolidated balance sheet classification of lease assets and liabilities are as follows:

(In thousands)

Assets

September 30, 2019

Operating lease right-of-use assets, beginning balance

$

1,608

Current period amortization

(81

)

Total operating lease right-of-use asset

$

1,527

(In thousands)

Liabilities

September 30, 2019

Operating lease liabilities - current

$

237

Operating lease liabilities - non-current

1,304

Total lease liabilities

$

1,541

Schedule of Future Minimum Lease Payments

Future minimum lease payments as of September 30, 2019 under non-cancellable operating leases are as follows:

(In thousands)

For the Year Ended June 30,

September 30, 2019

2020

$

292

2021

414

2022

425

2023

434

2024

258

Thereafter

188

Total lease payments

2,011

Less: imputed interest

470

Operating lease liability

1,541

Less: operating lease liabilities - current

237

Operating lease liabilities - non-current

$

1,304

X

- Definition
Schedule of condensed consolidated balance sheet classification of lease assets and liabilities.
+ References
No definition available.
+ Details

Name: astc_ScheduleOfCondensedConsolidatedBalanceSheetClassificationOfLeaseAssetsAndLiabilitiesTableTextBlock

Namespace Prefix: astc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_LeasesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R4.htm IDEA: XBRL DOCUMENT v3.19.3

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended

Sep. 30, 2019

Sep. 30, 2018

Income Statement [Abstract]

Revenue $ 1 $ 33

Cost of revenue 0 11

Gross profit 1 22

Operating expenses:

Selling, general and administrative 1,202 1,144

Research and development 855 1,103

Total operating expenses 2,057 2,247

Loss from operations (2,056) (2,225)

Interest and other expense, net (12) (13)

Loss from operations before income taxes (2,068) (2,238)

Income tax benefit 0 0

Net loss $ (2,068) $ (2,238)

Weighted average common shares outstanding:

Basic and diluted 5,591 4,073

Basic and diluted net loss per common share:

Net loss $ (0.37) $ (0.55)

Other comprehensive loss, net of tax:

Net loss $ (2,068) $ (2,238)

Available-for-sale securities:

Reclassification adjustment for realized loss 0 31

Total comprehensive loss $ (2,068) $ (2,207)

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate cost of goods produced and sold and services rendered during the reporting period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_CostOfRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDilutedAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized loss realized upon the write-down of available-for-sale securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=118930883&loc=d3e689-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 17A
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL34724391-108580

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373
+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_SellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 52 R26.htm IDEA: XBRL DOCUMENT v3.19.3

Going Concern (Details) - USD ($)
$ in Thousands
3 Months Ended 11 Months Ended 12 Months Ended

Apr. 17, 2019

Oct. 09, 2018

Sep. 30, 2019

Sep. 30, 2018

Sep. 30, 2019

Jun. 30, 2019

Sep. 05, 2019

Organization Consolidation And Presentation Of Financial Statements [Line Items]

Working capital $ 400 $ 400

Net loss 2,068 $ 2,238 $ 7,500

Net cash used in operating activities (1,830) (2,247) $ (8,500)

Proceeds from issuance of private placement of equity securities $ 2,000 $ 3,000

Net proceeds from sale of common stock $ 321 $ 0 $ 1,400

Secured Promissory Note | Private Placement

Organization Consolidation And Presentation Of Financial Statements [Line Items]

Secured note principal amount $ 1,500

X

- Definition
Organization consolidation and presentation of financial statements.
+ References
No definition available.
+ Details

Name: astc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems

Namespace Prefix: astc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Working Capital (Deficit) Surplus
+ References
No definition available.
+ Details

Name: astc_WorkingCapitalDeficitSurplus

Namespace Prefix: astc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400
+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from the additional capital contribution to the entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfPrivatePlacement

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_DebtInstrumentAxis=astc_SecuredPromissoryNoteMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 53 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 54 R37.htm IDEA: XBRL DOCUMENT v3.19.3

Common Stock Compensation - Stock Options by Exercise Price (Details)
3 Months Ended

Sep. 30, 2019

$ / shares

shares

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Exercise price lower range $ 2.83

Exercise price upper range $ 8.35

Number outstanding | shares 324,153

Options Outstanding Weighted- Average Remaining Contractual Life 5 years 6 months 21 days

Weighted average exercise price $ 5.71

Number exercisable | shares 236,075

Options exercisable weighted average exercise price $ 5.26

$2.83 – 3.55

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Exercise price lower range 2.83

Exercise price upper range $ 3.55

Number outstanding | shares 70,500

Options Outstanding Weighted- Average Remaining Contractual Life 2 years 8 months 23 days

Weighted average exercise price $ 3.39

Number exercisable | shares 70,500

Options exercisable weighted average exercise price $ 3.39

$5.30 – 5.85

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Exercise price lower range 5.30

Exercise price upper range $ 5.85

Number outstanding | shares 123,653

Options Outstanding Weighted- Average Remaining Contractual Life 7 years 7 months 9 days

Weighted average exercise price $ 5.48

Number exercisable | shares 79,575

Options exercisable weighted average exercise price $ 5.48

$6.00 – 8.35

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Exercise price lower range 6.00

Exercise price upper range $ 8.35

Number outstanding | shares 130,000

Options Outstanding Weighted- Average Remaining Contractual Life 5 years 1 month 24 days

Weighted average exercise price $ 7.19

Number exercisable | shares 86,000

Options exercisable weighted average exercise price $ 6.59

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(iii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=astc_ExercisePriceRangeOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=astc_ExercisePriceRangeTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=astc_ExercisePriceRangeThreeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 55 R33.htm IDEA: XBRL DOCUMENT v3.19.3

Term Note Payable - Related Party - Additional Information (Details) - Secured Promissory Note - Private Placement
$ in Millions

Sep. 05, 2019

USD ($)

Debt Instrument [Line Items]

Secured note principal amount $ 1.5

Interest on the Note 11.00%

Maturity date Sep. 05, 2020

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400
+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(2))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_DebtInstrumentMaturityDate

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_DebtInstrumentAxis=astc_SecuredPromissoryNoteMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 56 R10.htm IDEA: XBRL DOCUMENT v3.19.3

Leases
3 Months Ended

Sep. 30, 2019

Leases [Abstract]

Leases
(3) Leases

As of July 1, 2019, the Company adopted Topic 842, using the modified retrospective method of adoption. Astrotech elected to use the transition option that allows the Company to initially apply the new lease standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the year of adoption. Comparable periods continue to be presented under the guidance of the previous standard, Accounting Standards Codification (“ASC”) Topic 840. Topic 842 requires lessees to recognize a lease liability and ROU asset on the balance sheet for operating leases. The adoption of Topic 842 resulted in an adjustment to retained earnings of $230 thousand.

The Company has two existing facility leases and several small equipment leases. Astrotech leases office space consisting of 5,219 square feet in Austin, Texas and houses executive management, finance and accounting, and marketing and communications. The lease began in November 2016 and expires in December 2023 with a provision to renew and extend the lease for the entire premises for one renewal term of five years. Astrotech must, in writing, advise the landlord of its intention to renew the lease at least eight months before the expiration of its current lease in order to renew the lease. In May 2013, 1^st Detect completed build-out of a 16,540 square foot leased research and development and production facility in Webster, Texas. This facility is equipped with state-of-the-art laboratories, a clean room, a production shop, and offices for staff. The term of the lease is 62 months and includes options to extend for two additional five-year periods. In February 2015, 1^st Detect exercised its right of first refusal on the adjoining space of 9,138 square feet. The original lease began in May 2013 and was to expire in June 2018; these dates were amended in October 2014 with the amended lease beginning February 1, 2015, and expiring April 30, 2020, with provisions to renew and extend the lease for the entire premises, but not less than the entire premises, for two renewal terms of five years each. On June 1, 2018, the Company entered into its third amendment of the original lease removing 8,118 square feet from its leased space, leaving leased premises with a total square footage of 17,560. The Company included the assumption that 1^st Detect will occupy comparable space to its current location with a new five-year lease in its calculations for adopting Topic 842. The Company has not entered into any financing leases.

Operating lease assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate used at adoption was 11%. Significant judgement is required when determining the Company’s incremental borrowing rate. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

The condensed consolidated balance sheet classification of lease assets and liabilities are as follows:

(In thousands)

Assets

September 30, 2019

Operating lease right-of-use assets, beginning balance

$

1,608

Current period amortization

(81

)

Total operating lease right-of-use asset

$

1,527

(In thousands)

Liabilities

September 30, 2019

Operating lease liabilities - current

$

237

Operating lease liabilities - non-current

1,304

Total lease liabilities

$

1,541

Future minimum lease payments as of September 30, 2019 under non-cancellable operating leases are as follows:

(In thousands)

For the Year Ended June 30,

September 30, 2019

2020

$

292

2021

414

2022

425

2023

434

2024

258

Thereafter

188

Total lease payments

2,011

Less: imputed interest

470

Operating lease liability

1,541

Less: operating lease liabilities - current

237

Operating lease liabilities - non-current

$

1,304

Cash payments for operating leases for the three months ended September 30, 2019 totaled $96 thousand. The weighted-average remaining lease term for operating leases is 5.1 years.

X

- References
No definition available.
+ Details

Name: us-gaap_LeasesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-URI http://asc.fasb.org/subtopic&trid=77888251
+ Details

Name: us-gaap_LesseeOperatingLeasesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 57 R14.htm IDEA: XBRL DOCUMENT v3.19.3

Fair Value Measurement
3 Months Ended

Sep. 30, 2019

Fair Value Disclosures [Abstract]

Fair Value Measurement
(7) Fair Value Measurement

The accounting standard for fair value measurements defines fair value, establishes a market-based framework or hierarchy for measuring fair value, and expands disclosures about fair value measurements. The standard is applicable whenever assets and liabilities are measured and included in the financial statements at fair value.

The fair value hierarchy established in the standard prioritizes the inputs used in valuation techniques into three levels as follows:

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 - Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities.

As of September 30, 2019, the fair value of the Company’s cash and cash equivalents approximate their carrying value due to their short-term nature.

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 58 R18.htm IDEA: XBRL DOCUMENT v3.19.3

Income Taxes
3 Months Ended

Sep. 30, 2019

Income Tax Disclosure [Abstract]

Income Taxes
(11) Income Taxes

The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. Valuation allowances are established, when necessary, to reduce deferred tax assets to amounts that are more likely than not to be realized. As of September 30, 2019, the Company established a valuation allowance against all of its net deferred tax assets.

For the three months ended September 30, 2019 and 2018, the Company incurred pre-tax losses in the amount of $2.1 million and $2.2 million, respectively. The total effective tax rate was approximately 0% for the each of the three months ended September 30, 2019 and 2018.

For the each of the three months ended September 30, 2019 and 2018, the Company’s effective tax rate differed from the federal statutory rate of 21%, primarily due to the valuation allowance placed against its net deferred tax assets.

The Tax Cuts and Jobs Act was enacted on December 22, 2017 and provides for a refundable credit of any AMT previously paid. The AMT credit receivable by the Company of $857 thousand for AMT previously paid will be refunded subsequent to the filing of returns for fiscal years ending June 30, 2019, June 30, 2020, June 30, 2021 and June 30, 2022. Credit amounts calculated for such years are $429 thousand, $214 thousand, $107 thousand, and $107 thousand, respectively.

FASB ASC 740, “Income Taxes” addresses the accounting for uncertainty in income tax recognized in an entity’s financial statements and prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken or expected to be taken on a tax return. The Company had no unrecognized tax benefit for the three months ended September 30, 2019 or 2018.

Loss carryovers are generally subject to modification by tax authorities until three years after they have been utilized; as such, the Company is subject to examination for the fiscal years ended 2000 through present for federal purposes and fiscal years ended 2006 through present for state purposes. The reason for this extended examination period is due to the utilization of the loss carryovers generated by the sale of our Astrotech Space Operations business unit in fiscal year 2015.

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680
+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

Common Stock Compensation - Stock Option Activity (Details) shares in Thousands	3 Months Ended
	Sep. 30, 2019 $ / shares shares
Shares
Outstanding, beginning of period \| shares	324
Granted \| shares	0
Exercised \| shares	0
Canceled or expired \| shares	0
Outstanding, end of period \| shares	324
Weighted Average Exercise Price
Outstanding, beginning of period \| $ / shares	$ 5.71
Granted \| $ / shares	0
Exercised \| $ / shares	0
Canceled or expired \| $ / shares	0
Outstanding, end of period \| $ / shares	$ 5.71

Segment Information - Narrative (Details) - segment	3 Months Ended	12 Months Ended
Segment Information - Narrative (Details) - segment	Sep. 30, 2019	Jun. 30, 2019
Segment Reporting [Abstract]
Number of reportable business unit	1	2

General Information (Policies)	3 Months Ended
General Information (Policies)	Sep. 30, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation – The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the year ending June 30, 2020. These financial statements should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2019.
Our Business Units	Our Business Units Astrotech Technology, Inc. There are a number of different market opportunities for the mass spectrometry technology that was originally developed by 1^st Detect Corporation (“1^st Detect”). Astrotech Technology, Inc. (“ATI”) was formed to own and license the intellectual property, which includes 37 patents granted with five additional patents in process, for different fields of use. ATI currently licenses the intellectual property to 1^st Detect for use in the security and detection market and to Agriculture Technology Corporation (“AG-TECH”) for use in the agriculture market. 1^st Detect Corporation 1^st Detect, a licensee of ATI, has developed the TRACER 1000™, the world’s first certified mass spectrometer (“MS”)-based explosives trace detector (“ETD”), designed to replace the explosives and narcotics trace detectors used at airports, secured facilities, and borders worldwide. Agriculture Technology Corporation AG-TECH, a licensee of ATI, has developed the AG-LAB-1000™ series of mass spectrometers for use in the agriculture market. The technology can detect trace levels of pesticides in agricultural products in real-time and it has garnered initial interest from the hemp and cannabis market. It can characterize and quantify the cannabinoids (including tetrahydrocannabinol (“THC”), cannabidiol (“CBD”), and many other constituents) and terpenes (aromatic oils) present in the plant or plant derivatives. Astral Images Corporation Astral Images Corporation (“Astral”) developed advanced film restoration and enhancement software. Although we believe Astral has developed valuable technology fortified by patents and trade secrets, the potential market has not yet evolved. Due to funding constraints, the Company’s primary focus remains on the pursuit of opportunities for its platform mass spectrometry technology. Consequently, headcount and expenditures at Astral have been minimized and new development is exclusively focused on strategic initiatives that would facilitate the realization of Astral’s value.
Accounting Pronouncements	Accounting Pronouncements – In February 2016, the Financial Standards Accounting Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-02: Leases (“Topic 842” or “ASU 2016-02”) and ASU 2018-10: Codification Improvements to Topic 842, Leases (“ASU 2018-10”) which provide an additional (and optional) transition method whereby the new lease standard is applied at the adoption date and recognized as an adjustment to retained earnings. This ASU requires lessees to recognize a right-of-use (“ROU”) asset and lease liability on the balance sheet for all leases, with the exception of short-term leases. The asset will be based on the liability, subject to adjustment, such as for initial direct costs. For statement of operations purposes, leases are still required to be classified as either operating or financing. Operating leases will result in straight-line expense while financing leases will result in a front-loaded expense pattern. On July 1, 2019, the Company adopted Topic 842 using the modified retrospective approach and the impact of the adoption of Topic 842 resulted in the recognition of an ROU asset and lease obligation on the Company’s condensed consolidated balance sheets of approximately $1.6 million and an adjustment to retained earnings of $230 thousand. This application of the modified retrospective method will result in a balance sheet presentation that will not be comparable to the prior period in the first year of adoption. Results for reporting periods after July 1, 2019 are presented under Topic 842, while prior periods have not been adjusted. The Company elected the package of practical expedients permitted under the transition guidance within the new standard which, among other things, allowed the Company to carry forward the historical lease classifications. See Note 3 Leases for more information. In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. For assets held at amortized cost basis, ASU 2016-13 eliminates the probable initial recognition threshold in current generally accepted accounting standards, and, instead, requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For available-for-sale debt securities, credit losses should be measured in a manner similar to current generally accepted accounting standards; however, ASU 2016-13 will require that credit losses be presented as an allowance rather than as a write-down. ASU 2016-13 affects entities holding financial assets and net investment in leases that are not accounted for at fair value through net income. This amendment affects loans, debt securities, trade receivables, net investments in leases, off balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of this standard and does not believe it will have a material impact on its financial statements. In August 2018, the FASB issued ASU 2018-13, “Fair Value measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”). ASU 2018-13 removes certain disclosure requirements, including the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. ASU 2018-13 also adds disclosure requirements, including changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements, and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. ASU 2018-13 is effective for annual reporting periods, and interim periods therein, beginning after December 15, 2019, with early adoption permitted. The amendments on changes in unrealized gains and losses, and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The Company does not expect the adoption of this guidance to have a material impact on its financial statements.
Income Taxes	FASB ASC 740, “Income Taxes” addresses the accounting for uncertainty in income tax recognized in an entity’s financial statements and prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken or expected to be taken on a tax return. The Company had no unrecognized tax benefit for the three months ended September 30, 2019 or 2018. Loss carryovers are generally subject to modification by tax authorities until three years after they have been utilized; as such, the Company is subject to examination for the fiscal years ended 2000 through present for federal purposes and fiscal years ended 2006 through present for state purposes. The reason for this extended examination period is due to the utilization of the loss carryovers generated by the sale of our Astrotech Space Operations business unit in fiscal year 2015.

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2019	Jun. 30, 2019
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	15,000,000	15,000,000
Common stock, shares issued (in shares)	6,188,198	6,184,698
Common stock, shares outstanding (in shares)	5,926,137	5,775,171
Treasury stock, shares at cost (in shares)	399,916	399,916
Convertible Preferred Stock
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	2,500,000	2,500,000
Series C Convertible Preferred Stock
Preferred stock, shares issued (in shares)	280,898	280,898
Preferred stock, shares outstanding (in shares)	280,898	280,898
Series D Convertible Preferred Stock
Preferred stock, shares issued (in shares)	280,898	280,898
Preferred stock, shares outstanding (in shares)	280,898	280,898

General Information - Additional Information (Details) $ in Thousands	Sep. 30, 2019 USD ($) Patent	Jul. 01, 2019 USD ($)
General Information [Line Items]
Number of patents granted \| Patent	37
Number of additional patents in process \| Patent	5
ROU asset	$ 1,527	$ 1,608
Lease obligation	$ 1,541
ASU 2016-02
General Information [Line Items]
ROU asset		1,600
Lease obligation		1,600
Cumulative impact of change in accounting policy		$ 230

Leases - Schedule of Future Minimum Lease Payments (Details) $ in Thousands	Sep. 30, 2019 USD ($)
Leases [Abstract]
2020	$ 292
2021	414
2022	425
2023	434
2024	258
Thereafter	188
Total lease payments	2,011
Less: imputed interest	470
Total lease liabilities	1,541
Operating lease liabilities - current	237
Operating lease liabilities, non - current	$ 1,304

Common Stock Compensation - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate intrinsic value of options exercisable	$ 0
Remaining stock-based compensation expense	$ 106
Weighted average recognition period on remaining share-based compensation expense	7 months 9 days
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized	$ 44	$ 41
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average recognition period on remaining share-based compensation expense	2 years 2 months 1 day
Compensation expense recognized	$ 60	$ (5)
Remaining stock-based compensation expense	$ 496

Net Loss per Share - Narrative (Details)	3 Months Ended
Net Loss per Share - Narrative (Details)	Sep. 30, 2019 $ / shares shares
Earnings Per Share [Abstract]
Options to purchase (in shares) \| shares	324,153
Exercise price lower range (in dollars per share)	$ 2.83
Exercise price upper range (in dollars per share)	$ 8.35

Condensed Consolidated Statement of Changes in Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Preferred Stock Class C	Preferred Stock Class D	Common Stock	Treasury Stock Amount	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Balance, beginning of period at Jun. 30, 2018	$ 3,992			$ 190,570	$ (4,128)	$ 1,745	$ (184,164)	$ (31)
Balance (in shares) at Jun. 30, 2018				4,097
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net change in available-for-sale debt and marketable equity securities	31							$ 31
Adjustment to opening retained earnings related to adoption of ASC Topic 842 \| ASU 2016-02	0
Stock-based compensation	44					44
Cancellation of restricted stock	(14)			$ (14)
Cancellation of restricted stock (in shares)				(5)
Forfeiture of stock options	(3)					(3)
Exercise of stock options	7					7
Exercise of stock options (in shares)				3
Share repurchases	(1)				(1)
Restricted stock issuance	9			$ 9
Net loss	(2,238)						(2,238)
Balance, end of period at Sep. 30, 2018	1,827			$ 190,565	(4,129)	1,793	(186,402)
Balance (in shares) at Sep. 30, 2018				4,095
Balance, beginning of period at Jun. 30, 2019	2,708			$ 190,571	(4,129)	7,964	(191,698)
Balance (in shares) at Jun. 30, 2019		281	281	5,775
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Adjustment to opening retained earnings related to adoption of ASC Topic 842 \| ASU 2016-02	230						230
Issuance of shares	321					321
Issuance of shares (in shares)				146
Stock-based compensation	78					78
Restricted stock issuance	26			$ 26
Restricted stock issuance (in shares)				5
Net loss	(2,068)						(2,068)
Balance, end of period at Sep. 30, 2019	$ 1,295			$ 190,597	$ (4,129)	$ 8,363	$ (193,536)
Balance (in shares) at Sep. 30, 2019		281	281	5,926

Leases - Additional Information (Details) $ in Thousands	1 Months Ended			3 Months Ended
Leases - Additional Information (Details) $ in Thousands	Nov. 30, 2016 ft² renewal_term	Oct. 31, 2014 renewal_term	May 31, 2013 ft² renewal_term	Sep. 30, 2019 USD ($)	Jul. 01, 2019 USD ($)	Jun. 01, 2018 ft²	Feb. 28, 2015 ft²
Leases [Line Items]
Incremental borrowing rate				11.00%
Cash payments \| $				$ 96
Weighted-average remaining lease term for operating leases				5 years 1 month 6 days
1st Detect
Leases [Line Items]
Lease, expiration date		Apr. 30, 2020
Lessee, Operating Lease, Existence of Option to Extend [true false]		true
Number of renewal terms \| renewal_term		2
Renewal term		5 years
Leased premises, right of first refusal exercised							9,138
Austin, Texas
Leases [Line Items]
Leased premises	5,219
Lease, expiration date	Dec. 31, 2023
Lessee, Operating Lease, Existence of Option to Extend [true false]	true
Number of renewal terms \| renewal_term	1
Renewal term	5 years
Period before expiration of lease that renewal contract must be signed	8 months
Webster, Texas
Leases [Line Items]
Original lease area of land removed						8,118
Leased premises remaining area						17,560
Webster, Texas \| 1st Detect \| Research and Development and Production Facility
Leases [Line Items]
Leased premises			16,540
Lease, expiration date			Jun. 30, 2018
Lessee, Operating Lease, Existence of Option to Extend [true false]			true
Number of renewal terms \| renewal_term			2
Renewal term			5 years
Lease term			62 months
ASU 2016-02
Leases [Line Items]
Cumulative impact of change in accounting policy \| $					$ 230

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Sep. 30, 2019	Nov. 08, 2019
Cover [Abstract]
Entity Registrant Name	ASTROTECH Corp
Entity Central Index Key	0001001907
Trading Symbol	ASTC
Current Fiscal Year End Date	--06-30
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Document Type	10-Q
Document Period End Date	Sep. 30, 2019
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		5,915,129
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	001-34426
Entity Tax Identification Number	91-1273737
Entity Address, Address Line One	201 West 5th Street
Entity Address, Address Line Two	Suite 1275
Entity Address, City or Town	Austin
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	78701
City Area Code	512
Local Phone Number	485-9530
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common Stock, $0.001 par value per share
Security Exchange Name	NASDAQ
Entity Incorporation, State or Country Code	DE
Document Quarterly Report	true
Document Transition Report	false

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
Revenue	$ 1	$ 33
Cost of revenue	0	11
Gross profit	1	22
Operating expenses:
Selling, general and administrative	1,202	1,144
Research and development	855	1,103
Total operating expenses	2,057	2,247
Loss from operations	(2,056)	(2,225)
Interest and other expense, net	(12)	(13)
Loss from operations before income taxes	(2,068)	(2,238)
Income tax benefit	0	0
Net loss	$ (2,068)	$ (2,238)
Weighted average common shares outstanding:
Basic and diluted	5,591	4,073
Basic and diluted net loss per common share:
Net loss	$ (0.37)	$ (0.55)
Other comprehensive loss, net of tax:
Net loss	$ (2,068)	$ (2,238)
Available-for-sale securities:
Reclassification adjustment for realized loss	0	31
Total comprehensive loss	$ (2,068)	$ (2,207)

Going Concern (Details) - USD ($) $ in Thousands			3 Months Ended		11 Months Ended	12 Months Ended
Going Concern (Details) - USD ($) $ in Thousands	Apr. 17, 2019	Oct. 09, 2018	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Jun. 30, 2019	Sep. 05, 2019
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Working capital			$ 400		$ 400
Net loss			2,068	$ 2,238		$ 7,500
Net cash used in operating activities			(1,830)	(2,247)		$ (8,500)
Proceeds from issuance of private placement of equity securities	$ 2,000	$ 3,000
Net proceeds from sale of common stock			$ 321	$ 0	$ 1,400
Secured Promissory Note \| Private Placement
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Secured note principal amount							$ 1,500

Common Stock Compensation - Stock Options by Exercise Price (Details)	3 Months Ended
	Sep. 30, 2019 $ / shares shares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price lower range	$ 2.83
Exercise price upper range	$ 8.35
Number outstanding \| shares	324,153
Options Outstanding Weighted- Average Remaining Contractual Life	5 years 6 months 21 days
Weighted average exercise price	$ 5.71
Number exercisable \| shares	236,075
Options exercisable weighted average exercise price	$ 5.26
$2.83 – 3.55
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price lower range	2.83
Exercise price upper range	$ 3.55
Number outstanding \| shares	70,500
Options Outstanding Weighted- Average Remaining Contractual Life	2 years 8 months 23 days
Weighted average exercise price	$ 3.39
Number exercisable \| shares	70,500
Options exercisable weighted average exercise price	$ 3.39
$5.30 – 5.85
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price lower range	5.30
Exercise price upper range	$ 5.85
Number outstanding \| shares	123,653
Options Outstanding Weighted- Average Remaining Contractual Life	7 years 7 months 9 days
Weighted average exercise price	$ 5.48
Number exercisable \| shares	79,575
Options exercisable weighted average exercise price	$ 5.48
$6.00 – 8.35
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price lower range	6.00
Exercise price upper range	$ 8.35
Number outstanding \| shares	130,000
Options Outstanding Weighted- Average Remaining Contractual Life	5 years 1 month 24 days
Weighted average exercise price	$ 7.19
Number exercisable \| shares	86,000
Options exercisable weighted average exercise price	$ 6.59

Term Note Payable - Related Party - Additional Information (Details) - Secured Promissory Note - Private Placement $ in Millions	Sep. 05, 2019 USD ($)
Debt Instrument [Line Items]
Secured note principal amount	$ 1.5
Interest on the Note	11.00%
Maturity date	Sep. 05, 2020